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The maternal physiological state during pregnancy have an excess demand for oxygen 
supply which can easily disrupt the redox homeostasis balance. There is a change in the 
maternal haemodynamic profile with an increased cardiac output, reduced systemic 
vascular resistance and blood pressure (de Haas et al., 2017). In response to this high 
oxygen demand red blood cell (RBC) mass level steadily increases by 20-30% from 8 to 
10 weeks of the gestational period till the end of pregnancy (Foley, 2018). In connection 
to that, there are increasing evidences of enhanced oxidative insults during intrauterine 
development leading to severe abnormalities or pathological states like spontaneous 
miscarriage, preterm delivery, preeclampsia, ectopic pregnancy, intrauterine growth 
restriction (IUGR), placental abruption, perinatal death etc. Moreover, in cases of 
multiple/twin pregnancy there is an additional stress with the greater risks of miscarriage, 
anaemia, preterm delivery, gestational hypertensive disorders, IUGR, diabetes operative 
delivery and related postnatal and neonatal illnesses. Modern usage of in-vitro fertilization 
(IVF) therapies led to higher incidence of multiple pregnancies. There have been relevant 
data on the increasing foetal, neonatal and perinatal mortality rate of 3-6 times in twin and 
5-15 times in other multiple pregnancies with comparison to the singleton pregnancies.  
During pregnancy, the connection between the mother and the foetus is provided by 
the placenta and the umbilical cord. The umbilical cord vascular system is the sole pathway 
of oxygen and nutrient transport to the foetus from the placenta. Therefore, the major 
obstetric complications are directly or indirectly connected to the placental or umbilical 
cord disorders causing intrauterine hypoxia and/or impaired blood flow to the developing 
foetus. The major part of umbilical cord lacks innervations and hence the vascular tone is 
mainly regulated by nitric oxide (NO), i.e. derived from the endothelial nitric oxide 
synthase (NOS3). The NO being a potent vasoactive agent causes vasodilation and 
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increases the rate of perfusion, nutrient and oxygen supply. Usually intensive prenatal care 
and surveillances are done in high risk cases like multiple/twin pregnancy by the advanced 
non-invasive biomedical devices. The usage of high performance equipment like Blood 
oxygen level-dependent–magnetic resonance imaging was utilized to study changes in the 
placental oxygenation status in human pregnancies. It can also assess the placental 
perfusion and oxygen transport. Similarly, ultrasound and Doppler flow measuring 
techniques, not only can visualize the umbilical cord but simultaneously can assess the 
foetal blood flow parameters through the umbilical cord vessels. These approaches can 
easily detect any abnormalities in the umbilical cord circulation, but lacks to highlight the 
underlying molecular mechanisms behind any kind of impaired functionality in the foetal 
vascular system that can highly influence the in-utero development. Further on this topic 
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1. Introduction  
1.1. Demography and Implications of Multiple/Twin Pregnancy 
In the last 30 years, rates of twinning and multiple pregnancies have been increased to 
3% of all births worldwide (Young and Wylie, 2012). In the United States, the rate of twin 
birth increased by more than 75% from 1980 to 2009 (Figure 1), with similar trends in 
Western Europe and other countries (Bortolus et al., 1999; Pison and D’Addato, 2006; 
Collins, 2007; Martin et al., 2012). A detailed survey dataset by WHO also indicated that 
35.2% of multiple births were preterm delivery (< 37 weeks’ gestation); with 6.1% of births 
taking place at < 32 weeks’ gestation, 5.8% were during weeks 32 and 33 and the majority 
23.2% were during weeks 34 through 37 (Stock and Norman, 2010; Vogel et al., 2013). 
 
Figure 1: Twin Birth Rates, by Age of Mother: United States, 1980–2009 (Martin et 
al.; 2012)  
The graphical representation demonstrates twin birth rates increased for women of all ages over 
the three decades, with the largest increases among women aged 30 and over. From 1980 to 2009, 
rates increased by 76% for women aged 30–34, nearly 100% for women aged 35–39, and more 
than 200% for women aged 40 and over. 
A higher prevalence of multiple births has been observed in countries with high to 
middle socio-economic status. There is a diverse range of factors owing to the high risk of 
multiple pregnancies like (i) assisted reproductive technologies - IVF e.g. approximately 
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20% of twins in the UK Millennium Cohort study were conceived using IVF. (ii) Infertility 
therapy - usage of clomiphene citrate (selective oestrogen receptor modulator) prescribed 
to women with sub-fertility owing to an ovulation or oligo-ovulation. (iii) maternal age of 
women with more than ~35 years of age. (iv) genetic background (v) nutritional factors 
(Blondel and Kaminski, 2002; Jacobsson et al., 2004; Hayes, 2005; Jones et al., 2011; 
Gremeau et al., 2012). The background mechanism in the twinning depends on zygosity - 
one zygote (monozygotic, MZ) or two zygotes (dizygotic, DZ). MZ twins’ makeup 
approximately 30% of twin pregnancies and occur when one single embryonic mass 
divides. Further classification of MZs twins is based on chorionicity and amnionicity. MZ 
twins result in 33% dichorionic-diamniotic, 66% monochorionic–diamniotic and 1% 
monochorionic-monoamniotic. MZ twins having identical genetic traits in comparison to 
DZ. Major discordances between the MZ twins are mostly owed to common intrinsic and 
extrinsic stressor factors, unlike DZ twins which can get influenced by both genetic and 
environmental factors (Machin, 2009; Weber and Sebire, 2010). In general, ~ 16% of twin 
gestations have discordance i.e. difference in the weights of the foetuses (Miller et al., 
2012). As per the American College of Obstetricians and Gynaecologists (ACOG), 
discordant growth is a common phenomenon in cases of multiple or twin gestation. Most 
likely it gets associated with anomalies like IUGR, preterm birth, infection of one of the 
foetuses, umbilical arterial pH <7.1, and respiratory distress. In our experimental study 
design, we followed the consensus laid down by ACOG where the threshold of discordance 
has been considered to be a 15-25% difference in actual weight among the siblings 
(American College of Obstetricians and Gynecologists, 2016). The threshold of 




The variable risk factors that influence this divergence of growth in the twins are 
mainly due to maternal age > 35, higher rate of IVF, maternal tobacco intake, fluctuating 
change in the maternal body mass index, lack of prenatal care, monochorionic twin foetus, 
opposite sex of the foetuses, small for gestational age in either foetus (i.e. below <10th 
percentile) or trans placental viral infections (Bortolus et al., 1999; Choi et al., 2010). There 
are several instances where multiple/twin pregnancy gets associated with detrimental 
outcomes (Krotz et al., 2002; Norwitz et al., 2005; Pharoah et al., 2009) such as women 
going through IVF therapies imposes a greater risk of miscarriage, anaemia, hypertensive 
disorders like pre-eclampsia, gestational diabetes, operative deliveries and related 
postnatal illnesses (Sibai et al., 2000). Though the mortality rate is low, the associated 
morbidities increase by 2-3 times in women with a twin pregnancy. The twin foetuses are 
always at a higher risk ~ at least 6 times of developing chromosomal anomalies, cerebral 
palsy, birth asphyxia, hyaline membrane disease, respiratory disorders and long term 
developmental morbidities (Buhling et al., 2003; Obiechina et al., 2011). Around 60% of 
the twin cases are recorded as preterm birth (i.e. delivery before 37 weeks) and contribute 
to nearly 10-20% of all low birth weight neonates. Mostly the major complications in the 
twins are due to increased preterm birth and having low birth weight (<2500 gr), very low 
birth weight (<1500 gr), and extremely low birth weight (<1000 gr) ranges. In comparison 
to singleton births, foetal, neonatal, and perinatal mortality rates are 3–6 times higher in 
twins, where more than 60% of twin survivors suffer from significant health issues in their 





1.2. Fetoplacental Circulation  
During pregnancy, the normal circulatory dynamics in the foetus are unique. 
Understanding its changes both at the molecular and physiological level improves our 
knowledge regarding the pathophysiological mechanisms associated with impairment in 
the fetoplacental system. There had been several studies based on the morphological 
aspects of the placenta and umbilical cord that can assess the perinatal outcome and can be 
associated with pathological conditions like preeclampsia, foetal growth retardation, 
diabetes, and foetal demise (Di Naro et al., 2001).  
As a part of the fetoplacental circulation, the placenta is the foremost temporary, 
vascular part that is closely connected to the maternal uterine wall and majorly responsible 
for sustaining life in-utero. Intact placental circulation with adequate perfusion rate ensures 
the requisite supply of oxygen and nutrient substrates for the developing foetus along with 
the effective elimination of the metabolic wastes. The placenta has two separate circulatory 
blood systems, the maternal-placental (uteroplacental) circulation that processes blood 
flow from the mother end and the foetal–placental (fetoplacental) blood circulation from 




Figure 2: Illustration of Fetoplacental Circulation (www.stanfordchildrens.org) 
 
The next pivotal anatomical structure of the fetoplacental circulation is the umbilical 
cord (Figure 2). It is a unique mammalian foetal attachment to the centre of the placental 
disk that bridged the connection between the foetus and placenta (Blanchette, 2011). The 
umbilical cord protects the embedded vessels that participate in the transfer of nutrients 
and oxygen supply to the foetus. It also carries the blueprints that determine the intrauterine 
conditions throughout the in-utero development (Fahmy, 2018), and can be subjected to 
both intrinsic and extrinsic stressors leading to various pathophysiological processes 
(Hackshaw et al., 2011). The umbilical cord is 50-60 cm long, originates from the 
embryonic stem, and is formed by the fifth week of gestational development (Bydlowski 
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et al., 2009). Umbilical cord containing two arteries and a single vein that branches into 
the amnion (Figure 3) (Njaa, 2011; Benirschke et al., 2012a).  
 
Figure 3: Schematic Diagram of the Umbilical Cord Structure (Manuel Barrios Arpi; 
2019) 
The umbilical arteries carry deoxygenated and nutrient-depleted foetal blood from the 
foetus to the intervillous space where the maternal-foetal exchange of blood rich in oxygen 
and nutrients takes place and further the oxygenated blood and nutrients are carried by the 
umbilical vein (Weissman et al., 1994; Meekins et al., 1997; Spurway et al., 2012). The 
histological studies showed the characteristic features of the umbilical cord arteries and 
veins that have large lumen with irregular shapes. The umbilical cord vessels are 
constituted mainly by three layers’ tunica intima, media, and adventitia. The intima layer 
consists of elongated endothelium to the long axis of the blood vessel and lacks both 
internal and external elastic lamina. The endothelium of tunica intima corresponds to the 
thinnest layer comprised of simple squamous epithelium. The tunica media layer is located 
below the sub endothelial space and constitutes double-layered bundles of smooth muscles 
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containing collagen, elastic and reticular fibres with the presence of capillaries and absence 
of the elastic lamina. This layer distinctly consists of inner circular muscular layers and the 
outer longitudinal layer. The outermost tunica adventitia layer mainly forms the umbilical 
cord wall. This layer also consists of collagen, smooth muscle, and elastic fibres which 
partly invade the tunica media and muscle fibres. In contrast to “normal” arteries and veins, 
tunica adventitia varies in thickness and displays the number of transversal nerves in all 
thickness fibres which is completely absent in the umbilical vessels, thus both the umbilical 
arteries and vein lacks innervations (Manuel Barrios Arpi, 2019).  
The fetoplacental circulation from a very early onset of pregnancy gets adapted with 
efficient mechanisms to meet the requirements of the rapidly growing foetus. The main 
characteristic features are (i) there is no intermixing of the maternal and foetal blood (ii) 
There co-exists homeostatic balance between both the utero-placental and fetoplacental 
circulatory pathways and (iii) maintains a low placental vascular resistance and normal 
umbilical blood flow. In simple terms, the foetus possessed complicated physiology and 
different circulatory pathway with proportionally higher mass of “internal organs”. This 
fact suggests that the foetal system needs a greater amount of oxygen consumption 
compared to the adult which gets maintained by higher foetal cardiac output (Foley, 2018). 
The oxygen tension and saturation in the maternal part of the placental circulation is pivotal 
which gets continued through the foetal umbilical vein blood and thereby regulates and 
determines the foetal oxygenation status. However, the vascular endothelium of the 
umbilical cord vessels is highly vasoactive along their whole length (Mauro et al., 2011). 
Umbilical vessels liberate a wide range of vasoactive entities like serotonin, angiotensin II 
and oxytocin where the most potent and pivotal is NO, primarily derived from endothelial 
NOS. Mainly NO, regulates the vascular tone and normal functioning of the placenta and 
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umbilical cord throughout the gestation term for healthy foetal development (Karbowski 




1.3. Reactive Oxygen Species – friend or foe? 
A healthy state of pregnancy with normal in-utero foetal growth and subsequent 
survival of the perinatal period mainly depends on the vascular development and function 
of both the placenta and the umbilical cord. An orchestrated pattern of the uteroplacental 
and fetoplacental circulations is essential to meet the rising foetal demands for oxygen. To 
sustain this higher oxygen demand, the cellular metabolism rate increases with excessive 
production of reactive oxygen species (ROS). Chemical entities are containing an atom of 
oxygen with an unpaired electron termed as "free radicals" like as •NO, superoxide (O2
•–), 
hydroxyl radical (OH•), lipidperoxyradical (LOO•) that highly react with other 
radicals/non-radical in multiple ways which can be collectively termed as "oxidants” or 
ROS (Halliwell, 1991; Kalyanaraman, 2013; Phaniendra et al., 2015) 
Currently, in a way to rationalize the complex chemical interactions of the reactive 
species within themselves or their targets, a novel integrative concept defined as the 
reactive species interactome (RSI) has been introduced (Kuhn et al., 2017). RSI constitutes 
reactive oxygen species, reactive nitrogen species, and reactive sulfur species as important 
mediators or signalling molecules. Under a wide range of human reproductive 
physiological processes likewise follicular development, ovulation, fertilization, 
embryogenesis, corpus luteum and uterine function, placental differentiation, fetoplacental 
development, and growth, etc. RSI maintains a multilevel redox regulatory system (Al-
Gubory et al., 2010; Agarwal et al., 2012). It mainly targets the regulatory cysteine redox 
switches in proteins, affecting gene regulation, ion transport, intermediary metabolism, and 
mitochondrial function. This shows at physiological levels RSI has beneficiary roles in 
common (Nordberg and Arnér, 2001; Sharma et al., 2015; Kuhn et al., 2017). Under 
balanced redox homeostasis conditions, the physicochemical properties of the implied RSI 
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allow efficient sensing and rapid adaptation to environmental changes and various other 
stressors to elicit fitness and resilience response (Selye, 1955; Kültz, 2005; Mattson, 2008)  
Redox biological reactions are mostly considered to bear the Janus faceted feature, 
which can promote both physiological signalling responses and pathophysiological cues. 
The endogenous antioxidant system becomes an active part of these scenarios and follows 
a basic understanding of antioxidant-based therapeutic interventions in redox-related 
diseases (Tan et al., 2018). Antioxidant molecules are nucleophilic and reductant 
molecules that can react with oxidants. Antioxidants scavenge biologically important ROS 
like O2
•–, peroxynitrite (ONOO–), hydrogen peroxide (H2O2), OH
•, hypochlorous acid, 
ferryl, peroxyl, and alkoxyl, thus actively takes part in the biological repair mechanisms 
by limiting the ROS formation. There lies an intricate balance between ROS and the 
endogenous antioxidant system to carry out vital cell function, regulation, and adaptation 
to diverse growth conditions. Antioxidants also ensure a defense mechanism against ROS-
induced damage to lipids, proteins, and DNA (Young and Woodside, 2001; Espinosa-Diez 
et al., 2015).  
The cellular antioxidant systems are divided into two major groups, enzymatic 
detoxifiers like superoxide dismutases SOD1 (Cu, Zn-SOD) and SOD2 (Mn-SOD or 
SOD2), catalases, glutathione peroxidases which are the major defence pathways. The 
primary enzymatic antioxidant pathway i.e. followed is dismutation, where mainly SOD1 
and SOD2 catalyse O2
•– to H2O2 formation. The alterations in the expression and activity 
of the SODs signifies ROS level with subsequent oxidative stress (Hileman et al., 2001; 
Gongora et al., 2006; Mccord and Fridovich, 2014). Dysfunction or failure in the 
dismutation process abruptly increases the level of O2
•– that gets involved in the formation 
of deleterious pro-oxidants like ONOO− and •OH. Peroxynitrite is formed by a spontaneous 
reaction of O2
•− and •NO, (Koppenol et al., 1992; Packer et al., 1996; Kirkinezos and 
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Moraes, 2001) whereas highly reactive •OH gets generated with the interaction between 
O2
•− and H2O2 in the presence of free unbound iron ions, known as the Haber–Weiss 
reaction. Anyhow, the secondary antioxidative step limits the H2O2 production and its 
elimination before their subsequent transformation to •OH (Kehrer, 2000; Ježek and 
Hlavatá, 2005). 
Extensive studies were conducted within a wide array of defensive antioxidant 
mechanisms in the neonates or preterm infants during theirs in-utero foetal development. 
The overall antioxidant efficiency was found significantly low during the early stages of 
the first trimester that fails to counteract with harmful effects of the generated ROS species. 
This fact might lead to foetal or neonatal diseases and obstetric complications associated 
with prolonged oxidative stress conditions (Georgeson et al., 2002; Perrone et al., 2012, 
2019). The increased amount of radical/oxidants like •OH and ONOO− in the system 
enhances the rate of lipid peroxidation by subsequent ß cleavage of n-6 polyunsaturated 
fatty acids (PUFAs) (Marla et al., 1997). The most abundant and bioactive yield of lipid 
hydroperoxide product i.e. alkenal 4-hydroxy-2-trans-nonenal (4-HNE) (Benedetti et al., 
1980; Esterbauer et al., 1991) is estimated to determine the extent of macromolecular 
damages. The 4-HNE is highly reactive and can form adducts with DNA (Chung et al., 
2000; Nair et al., 2007), with phospholipids (containing PUFAs such as linoleic and 
arachidonic acid) and nucleophilic amino acids, such as cysteine, histidine, and lysine 
residues. Thus, even 4-HNE cross-linked conjugates propagated lipid peroxidation with 
subsequent damages and loss in redox homeostasis that lead to pathological disorders 




1.4. Oxidative Stress and Intrauterine Hypoxic Conditions 
The aetiological factors that are prone to cause an imbalance between the oxidants and 
antioxidants in favour of oxidants state the "oxidative stress" condition. Oxidative stress 
causes extensive oxidative macromolecular damages likewise in lipid, protein, and DNA 
with subsequent complications and severe pregnancy outcomes (Bak & Roszkowski, 2013; 
Burton & Jauniaux, 2011; Messner & Bernhard, 2014; Hubinont et al., 2015). Under 
additional stressor conditions like multiple/twin pregnancy, continuous adaptations were 
invoked within the maternal-placental-foetal interface by the process of “foetal 
programming” with epigenetic control. These further regulate and influence the 
development of non-communicable diseases such as diabetes, obesity, metabolic 
syndrome, and cardiovascular diseases in adulthood (Barker et al., 1993; Godfrey and 
Barker, 2001). Thus during multiple/twin pregnancy, the intrauterine environment 
remained as a key factor where both the mother and foetuses are exposed to the persistent 
hypoxic environment in the uteroplacental and fetoplacental circulation, respectively. The 
equilibrium conditions are particularly disturbed with an alteration in the intra-placental 
oxygen content.  
Since adequate perfusion and transfer of oxygen to the foetus is dependent on both 
uteroplacental and fetoplacental circulations, intrauterine hypoxia or foetal hypoxia can be 
classified into (i) pre-placental hypoxia – this occurs due to reduced oxygen content in the 
maternal blood. Here both the mother and the foetus is hypoxic which mainly occurs due 
to multiple pregnancies, maternal smoking, maternal anaemia and other chronic infections 
(ii) uteroplacental hypoxia – here the oxygen tension in the maternal blood are normal but 
due to any occlusion the oxygenated blood entry is restricted to the uteroplacental arterioles 
such as in the cases of pre-eclampsia and IUGR (iii) post placental hypoxia – the 
oxygenated maternal blood cannot perfuse in the fetoplacental circulation mainly due to 
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any congenital fetoplacental obstruction or disease (Kingdom and Kaufmann, 1997; 
Stanek, 2013).  
Therefore, an adverse in-utero environment arises due to continuous intrauterine pre-
placental, utero-placental, and post-placental hypoxic conditions. Here we mainly like to 
highlight the intrauterine pre-placental hypoxic state in cases of multiple/twin pregnancy 
that have a different spectrum of outcomes in both maternal and foetal conditions. Due to 
multiple pregnancies, the uterus gets highly distended with decreased oxygen pressure in 
the environment. This condition ultimately lowers the intra-placental oxygen content 
which hinders the maturation process of the utero-placental intervillous exchange surface 
causing low materno-foetal oxygen transfer. Thus there exists a chronic state of maternal 
hypoxemia (Kingdom and Kaufmann, 1997, 1999; Hutter et al., 2010; Stanek, 2013). The 
maternal blood with reduced oxygen content then passes through the placenta and flows 
into the foetus via the umbilical cord vein. This phenomenon causes acute foetal hypoxia 
with excessive activation of cellular stress signalling and inflammatory pathways in 
response to energy intake which might strongly exceed the energy expenditure. The 
fetoplacental circulation showed an abrupt reduction in the blood flow via arterial cord 
vessels leading to deprivation of oxygen and nutrients in the developing foetus, with 
consequent intrauterine hypoxia and malnutrition (Yoshida et al., 2018). 
Similar conditions of intrauterine pre-placental hypoxia also arise due to maternal 
smoking conditions during pregnancy where it increases the rate of lower birthweight in 
the new-borns and predisposes deleterious effects with chronic diseases in theirs later life 
(Hackshaw et al., 2011; Courtney et al., 2018). In cases of maternal cardiovascular 
complications and haematological disorders like sickle cell anaemia, directly affect the 
oxygen transfer to the foetus and are at higher risk for maternal (i.e., preterm labour, 
preterm rupture of membranes, and postpartum infections) and foetal complications (i.e., 
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abortion, prematurity, IUGR, low birth weight, and stillbirth) (Singla et al., 1997; Williams 
et al., 1997; Siu et al., 2002). Anyhow, cellular metabolism gets enhanced during normal 
pregnancy terms, which directs the antioxidant mechanisms reacting by way of enzyme 
activity and non-enzyme free radical deactivators to maintain the redox homeostasis 
balance. However, the aetiologies behind the development of such pathological conditions 
affecting female reproductive processes cannot be fully guarded by the selective 
endogenous antioxidant mechanisms as anticipated (Casas et al., 2015; Sies, 2015). This 
indicates our current understanding of the redox diseases underlying such 




1.5. Nitric Oxide Synthase Pathway – NO synthesis 
Foetal homeostatic conditions and the intrauterine environment critically depend on 
the efficiency of the placental and umbilical cord circulation. The prevalence of 
intrauterine hypoxic state causes vasoconstriction with the definite shortage in the 
bioavailable NO, elevation in the local oxidizing environment by triggering free radical 
generation, and chronic inflammatory reactions leading to severe oxidative stress 
conditions (Hutter et al., 2010; Zhou et al., 2020). As the umbilical cord lack innervations, 
in the fetoplacental system to maintain the vascular tone, cord vascular endothelium 
releases potent vasoactive substances like NO derived from endothelial NOS that acts as a 
central regulator for the maintenance of vascular homeostasis (Mauro et al., 2011; 
Benirschke et al., 2012b; Vanhoutte et al., 2017). Any kind of impaired response and loss 
in the bioactivity of endothelium-derived NO within the umbilical cord vascular system 
causes intrauterine hypoxia, increased fetoplacental vascular resistance, and retardation in 
the foetal growth (Tomasian et al., 2000; Prieto et al., 2011).  
The NOS isoforms are distinct from one another based on their gene origin, 
localization, regulation, catalytic properties, and inhibitor sensitivity. The common 
characteristic of all NOS isoforms is "dimeric" in their active form. These isoforms are 
referred to as nNOS/NOS1 predominantly found in neuronal tissue, iNOS/NOS2 being the 
isoform that is inducible in a wide range of cells and eNOS/NOS3 abundant in vascular 
endothelial cells. These NOS isoforms have been differentiated based on their constitutive 
NOS1 and NOS3 versus inducible NOS2 expression, and their calcium (Ca2+) dependence 
in the case of NOS3 and NOS1 or independence as like NOS2 (Alderton et al., 2001). The 
NOS1 in addition to perivascular nerve fibres also gets expressed in the vascular wall 
(Schwarz et al., 1999; Tsutsui, 2004) and atherosclerotic plaques (Schödel et al., 2009) and 
contributes to vasodilation (Capettini et al., 2011). Contrastingly, NOS2 under normal 
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physiological conditions is present in the vasculature but its expression mainly gets 
induced due to pathological states like inflammation, sepsis, or oxidative stress (Pautz et 
al., 2010; Yu et al., 2018). NOS2 serves as a widely diffusible and long-lasting source of 
NO that might adequately compensate for a fall in the NO level but due to its high catalytic 
activity compared to NOS3, it produces cytotoxic levels of NO and triggers cytokines and 
inflammatory reactions (Ratovitski et al., 1999; Colton et al., 2006). It had been also noted 
that endothelial and inducible nitric oxide synthases derived NO respectively regulated the 
vascular tone and even showed a wide range of pivotal roles in the placental vascular 
development, in-utero embryo implantation, and trophoblast invasion (Krause et al., 2011). 
In the endothelial cell, NOS3 is constitutively expressed and tightly gets regulated by 
its substrate L-arginine concentration, availability of cofactors, rate of electron transfers, 
subcellular localization, post-translational modifications, and diverse interacting proteins 
(Michel and Feron, 1997; Shu et al., 2015a). The process of NOS3 coupling/dimerization 
is the most crucial step towards its activation that can produce functional vasoprotective 
factor NO. Mechanistically deficiency of cofactors like tetrahydrobiopterin (BH4) and low 
concentration of L-arginine substrate is likely to be the major causes for NOS3 uncoupling 
and dysfunctionality (Förstermann & Münzel, 2006; Li & Förstermann, 2013; Li, Horke,& 
Förstermann, 2013). As mentioned in (Figure 4), initially the NOS3 resides in the Golgi 
apparatus, where it gets anchored to the membrane via one myristoyl and two palmitoyl 
groups (Liu et al., 1996; Özüyaman et al., 2008). Through the vesicular transport system, 
NOS3 localizes to the plasma membrane where it gets associated with caveolae. In the 
caveolae, NOS3 binds to caveolin-1 via its scaffolding domain and remains catalytically 
inactive (Feron et al., 1998). Due to receptor dependant agonists or by physical stimuli 
including shear stress the intracellular Ca2+ concentration increases, calmodulin binds to 





Figure 4: Regulation of NOS3 in the Endothelial Cells (Özüyaman et al., 2008) 
The representative figure describes in detail the regulatory pathway of NOS3 in the endothelial 
cells. NOS3 via vesicular transport gets transported to the plasma membrane from the Golgi 
apparatus and gets bound to caveolin-1 in the caveolae and remains inactive. Under increased shear 
stress conditions, the potassium channel activates with an increase in the intracellular Ca2+, leading 
to consecutive phosphorylation of NOS3 at Ser1177residue. 
 
The activated NOS3 enzyme translocated in the cytosol and via the PI3-Akt pathway 
gets phosphorylated at Ser1177 residue. In resting endothelial cells, Ser1177 is usually not 
phosphorylated. Post-translational modification of NOS3 by phosphorylation is induced 
when the cells are exposed to a kind of shear stress or other factors like vascular endothelial 
growth factor (VEGF). Human endothelial NOS have two important functional 
phosphorylation sites at Ser1177 and Thr495. The process of phosphorylation increases 
the influx of electrons through the reductase domain from NADPH to the haem in the 
oxygenase domain and enhances the enzyme activity of the kinases such as AMP-activated 
protein kinase, protein kinase A, serine/threonine kinase Akt and Ca2+/calmodulin 
dependent protein kinase II. In the presence of serine/threonine kinase Akt as shown in 
(Figure 5) NOS3 gets catalytically active by the phosphorylation at Ser1177 whereas 
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Thr495 residue of NOS3 acts as the negative regulatory site, and its phosphorylation is 
associated with a decreased electron influx and enzyme activity. 
 
Figure 5: Dimerization and Activation of NOS3 (Förstermann and Münzel, 2006) 
The above figure demonstrates the process of dimerization and regulation of NOS3 activity by 
intracellular Ca2+ and phosphorylation. NOS3 gets functionally active by important 
phosphorylation sites at Ser1177 and Thr495 residue. The intracellular Ca2+ facilitates the flow of 
electrons from NADPH in the reductase domain to the haem in the oxygenase domain. Through 
the PI3/Akt pathway, the NOS3 gets activated by phosphorylation at Ser1177 and deactivated by 
phosphorylation at Thr495 in the presence of protein kinase C.  
The post-translational modification leads to further activation of NOS3 which acts on 
its substrate L-arginine in the presence of cofactors like BH4, flavin-adenine-dinucleotide, 
flavin-mononucleotide, and nicotinamide-adenine-dinucleotide-phosphate that catalyses 
the reaction to form L-citrulline and produce bioavailable vasoactive NO (Dimmeler et al., 
1999; Fulton et al., 1999). The available L-arginine substrate concentration is pivotal for 
NOS3 activation, where NOS3 competes with Arginase that indirectly influences the 
NOS3 activation process (Durante et al., 2007; Pernow and Jung, 2013; Yang et al., 2013). 
Under severe oxidative stress conditions influenced by any intrinsic or extrinsic 
pathophysiological factors, there is obvious production of ROS like O2
•–, H2O2, and 
•OH. 
Alteration in the redox homeostasis induces elevated expression and activation of 
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Arginases (Silva et al., 2012; Lucas et al., 2014). The increased activation of Arginase 
“steals away” the common substrate L-arginine, i.e. required to generate NO and L-
citrulline. Due to depletion in the common L-arginine substrate concentration, the NOS3 
protein remained uncoupled in their inactive monomer state and produces an excess of O2
•– 
instead of vascular bioactive NO. The elevated level of O2
•– undergoes a spontaneous 
reaction and scavenges the limited bioavailable NO in the vascular system by forming a 
deleterious pro-oxidant ONOO− an entity (Cau et al., 2012; Yang and Ming, 2013; Lucas 
et al., 2014). Thus, any disruption in the redox homeostasis balance signifies endothelial 
dysfunction (ED) with impaired endothelial growth and vasodilation due to low 
bioavailable NO production in the vessels. 
ED stands as a hallmark for any kind of vascular comorbidities (Berk et al., 2000; 
Granger et al., 2001; Nedeljkovic et al., 2003). Chronic conditions e.g. oxidative stress, 
smoking, environmental pollutants, and oxidation of low-density lipoproteins cause drastic 
downregulation of bioavailable NO in the endothelium that leads to the consequences of 
ED (Ding and Triggle, 2005; Barthelmes et al., 2017). It contributes to the complications 
and diseases like diabetes, atherosclerosis, hypertension, obesity, asthma, 
neurodegenerative diseases, etc. These kinds of comorbidities collectively signify “redox 
diseases” (Schächinger et al., 2000; Heitzer et al., 2001; Watson, 2014; Casas et al., 2015).  
There has been strong evidence showed, NO released by the vascular endothelium has 
crucial roles and serves as an important endothelial-derived relaxation factor (Vanhoutte 
et al., 2017). Thus the development of ED mainly involves three major harmful NO 
associated events like (i) scavenging of NO due to overproduction of O2
•–, (ii) reduced 
vascular antioxidant capacity and (iii) altered NOS3 expression and its functional activity 
(Nedeljkovic et al., 2003; Montorfano et al., 2014; Krüger-Genge et al., 2019).  
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Endothelium being the innermost framework of all vascular systems acts as a major 
interface between blood circulation and diverse organ systems in regulating vascular 
homeostasis conditions, blood pressure, blood fluidity, or permeability (Krüger-Genge et 
al., 2019; Minami et al., 2019). It directly comes in contact with all the blood components 
and especially shares an intimate crosstalk with the predominant circulating RBCs. Red 
blood cells are unique in their both structural and functional features. In general, RBCs 
were mainly ascribed as carriers transmitting oxygen and NO into the vascular bed. The 
ground-breaking fact vividly described and demonstrated NO synthase (NOS) transcript 
and/or protein within RBCs (RBC NOS), showing an “erythrocrine function” that can 
synthesize and significantly contribute to the intravascular NO pool to regulate 
physiologically relevant mechanisms (Kleinbongard et al., 2006; Cortese-krott and Kelm, 
2014). Thus currently RBCs have been known to regulate vascular function through the 
modulation of oxygen delivery along with scavenging and generation of NO, so now RBCs 
are not only being considered as the "sink" but also the "source" for NO production. 
Though RBCs unlike endothelial cells lack cellular organelles like the nucleus, 
endoplasmic reticulum, and Golgi complex, we supposed that the RBC-derived NOS has 
common but distinct regulatory mechanisms (Figure 6) when compared with endothelial 




Figure 6: Possible Regulatory Pathway for RBC NOS (Özüyaman et al., 2008) 
The above figure illustrates the hypothetic cycle involving RBC NOS regulatory pathway. RBC 
NOS gets bound to caveolin-1 in the cytoplasm and is located near the lipid rafts in its inactive 
form. An influx of intracellular Ca2+ causes stimulation and further activation of NOS by 
phosphorylation at Ser1177 residue. 
Even though the redox regulation in RBCs, intervenes with numerous sources of 
oxidants including high levels of molecular oxygen that gets bound to haemoglobin, 
endogenously it has a well-equipped redox buffering system. Therefore, RBCs can 
maintain the redox balance and get actively involved in the regulation of vascular tone, 
especially during hypoxic and ischaemic conditions by the release of bioactive NO and 
adenosine triphosphate (Cortese-krott and Kelm, 2014; Kuhn et al., 2017). Under 
pathological states, the RBC redox status gets altered and fails to counteract the pro-
oxidant status of the microenvironment. Instead, RBCs themselves become a source of 
reactive species and consequently, its typical structural and functional features are lost 
(Minetti et al., 2007; Zhou et al., 2018a; Dugmonits et al., 2019). Based on an intimate 
crosstalk mechanism between the RBCs and vascular endothelium, Pernow and colleagues 
demonstrated that under disease states like Type 2 diabetes mellitus RBCs showed excess 
levels of ROS, marked alteration in their protein profile and enzymatic activities with 
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increased adhesion capabilities. This further induced and synergized the process of 
vascular impairment, termed as ‘erythropathy’ (Zhou et al., 2018a; Pernow et al., 2019b). 
Long-term intrauterine hypoxic conditions prevail during multiple/twin pregnancy, this 
intrinsic factor can regulate the short and long-term NO synthesis and its vasoactive effects 
in the umbilical cord vessels. Due to persistent hypoxia, via the intimate cross-talk 
mechanism, the redox homeostatic conditions both in the vascular endothelium and RBCs 




2. Aims  
The presence of intrauterine hypoxia causes excessive production of ROS and leads 
to foetal oxidative stress, which variedly contributes to the occurrence of pathological 
conditions in post-natal or adult life. From the clinical purview, comparison of singleton 
versus twin neonates always experience enhanced intrauterine hypoxia with advanced 
cellular stress conditions, that might directly or indirectly get associated with several RBC 
and umbilical cord disorders. The establishment of an efficient cross-talk between the 
vascular endothelium and circulating RBCs is necessary to improve the rate of blood flow 
in the cord vessels by vasodilation. The developmental status of neonates is mainly 
determined by several multifactorial and complex processes, where the involvement of the 
NOS3 signalling pathway and its subsequent activation steps becomes pivotal. The NOS3 
pathway significantly controls the level of bioavailable NO and in this way can modulate 
the supply of oxygen and nutrition to the developing foetus.  
In our work, taking into account the highly hypoxic intrauterine circumstances due to 
twin pregnancy, we have pursued the molecular and functional consequences and its 
harmful effects on the vascular cord endothelial layer and the circulating RBCs of the 
developing foetuses. We searched for major alterations in the regulatory parameters which 
play crucial roles in the NOS3 signalling pathway to maintain the bioavailable NO level. 
Further, we tried to shed light on the activation of any rescue/or compensatory mechanisms 
to combat the higher demand of bioavailable NO in both the umbilical cord vessels and 
foetal circulating RBCs. In detail following the NOS pathway, our study targeted to 
identify an early marker for cardiovascular disorders and/or other relevant comorbidities. 
In connection to this, we studied in detail to find answers for the following questions: - 
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 How do alterations in the NOS3 expression and its post-translational modifications 
along with the ROS-inducible NOS3 competitor of Arginase1 expression affects the 
functionality of the UC endothelial layer and circulating foetal RBCs?  
 Is there any evidence of the circulating foetal RBCs that can show a compensatory 
or alternative mechanism to increase the bioavailable NO level in the vessels?  
 What is the level of free radicals’/oxidants formation in the RBCs derived from the 
twins and the singletons?  
 What are the significant changes in the distribution pattern of different phenotypic 
variants in the RBC populations derived from singletons and twin populations? 
 What are the consequences/extent of damages occurred due to a higher level of pro-
oxidants both in the UC vessels and circulating RBCs?  
 Is there any connection between the birth weight of the foetus and the 




3. Materials and Methods 
3.1. Human samples 
In accordance with the Declaration of Helsinki, informed consent was collected from 
the pregnant women in order to procure a small portion of the umbilical cord along with 
foetal cord blood samples. The study protocol (16/2014; Investigation of oxidative stress 
markers in maternal and neonatal blood samples) was approved by the Ethics Committee 
from the Department of Obstetrics and Gynaecology at the University of Szeged, Hungary. 
The study protocol strictly followed several exclusions criteria for collection of the clinical 
samples such as (i) maternal age below 18 years, (ii) gestational diabetes, infection and 
inflammatory conditions or disorders such as cardiovascular diseases, (iii) complications 
or difficulty during delivery, (iv) dizygotic twin birth (v) foetal distress, (vi) malformations 
or evidence of genetic disorders and (vii) neonates born from mothers addicted to alcohol 
and /or smoking habit. The nutritional status of the mothers during pregnancy was 
satisfactory; no case of malnutrition occurred. 
The collected clinical samples were grouped under different inclusions criteria as 
mentioned:-In the first group, a total of 21 pairs of mature non-discordant twin neonates 
and 32 age- and weight-matched singletons were taken as controls in comparison. Twin 
neonates were categorized based on their birth weight; 3000 – 3200 gr (High birthweight 
twin-Hwt) and 2400–2600 gr (Low birthweight twin-Lwt) in comparison to age- and 
weight-matched singletons as High birthweight singleton (Hws) and Low birthweight 
singleton (Lws). Here, the clinical parameters of the study group and the maternal age are 
presented in the following Table 1. 
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Clinical Parameters Full-term single neonates Full-term twin 
neonates 
Numbers of Samples (N) Hws: N = 22 
Lws: N = 10 
Hwt: N = 24 
Lwt: N = 18 
Gestational age at delivery 
(weeks) 
37.52 ± 0.50  37.35 ± 0.47  
Birth weight (kg) 
  
APGAR score at 10 min 9.92 ± 0.27  9.69 ± 0.53  
Ratio of vaginal delivery 
/caesarean section  
28:4  34:8 
Maternal age (years) 29.5 ± 6.11  31.9 ± 7.12  
Blood sample pH 7.26 ± 0.13  7.29 ± 0.12  
Table 1. The clinical parameters of the study groups and the maternal age 
 
The second group consisted of clinical samples obtained from 16 pairs of premature 
non-discordant twin neonates. Similarly, the twin neonates were categorized based on their 
birthweight 2430-2570 gr (Premature High birthweight twin – Pr-Hwt) and 1940-1990 gr 
(Premature Low birthweight twin – Pr-Lwt). In this group as per the inclusion criteria 15 
age (33-35 weeks) and weight (2200-2500 gr) matched singleton samples were collected 
taken as control (Pr-Hws) for the Pr-Hwt group. The clinical parameters of the study group 
and the maternal age are presented  
in the following Table 2. 
Clinical Parameters Preterm single neonates Preterm twin 
neonates 
Numbers of Samples (N) Pr-Hws: N= 15 Pr-Hwt: N = 20 
Pr-Lwt: N = 12 
Gestational age at delivery 
(weeks) 




3.30 ± 0.172  
2.59 ± 0.171  
3.19 ± 0.073  
 
2.6 ± 0.174  
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Birth weight (kg) Pr-Hws: 2.41 ± 0.11  
Pr-Hwt: 2.47 ± 0.04  
Pr-Lwt: 1.97 ± 0.02  
APGAR score at 10 min 9.88 ± 0.32  9.56 ± 0.66  
Ratio of vaginal delivery 
/caesarean section  
12:3 22:10 
Maternal age (years) 30.52 ± 3.34  32.7 ± 4.73  
Blood sample pH 7.27 ± 0.07  7.25 ± 0.12  
Table 2. The clinical parameters of the study groups and the maternal age 
The third group in total considered 10 pairs of premature monozygotic discordant twin 
pair neonates with both monochorionic-diamniotic and dichorionic-diamniotic origin. The 
criteria for discordance was followed as per the guidelines laid down by ACOG USA, with 
a minimum of 25% discordance in their birthweight between the twin pairs. The twin pairs 
were compared and grouped according to their discordance in birthweight as 2600-2890 
gr/35-35+4 weeks (Premature Discordant High birthweight twin – PrD-Hwt) and 1860-
2040 gr/35-35+4 weeks (Premature Discordant Low birthweight twin – PrD-Lwt). The 
clinical parameters of the study group and the maternal age are presented in the following 
Table 3. 
Clinical Parameters Preterm Discordant twin neonates 
Numbers of Samples (N) 
PrD-Hwt: N= 20 
PrD-Lwt: N= 20 
Gestational age at delivery (weeks) 35.21 ± 0.23  
Birth weight (kg) 
PrD-Hwt: 2.63 ± 0.15  
PrD-Lwt: 1.87 ± 0.12 
APGAR score at 10 min 9.52 ± 0.65  
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Table 3. The clinical parameters of the study groups and the maternal age 
 
3.2. Red blood cell smear image processing and data analysis 
Using the validated calculation software MatLab tool CIDRE (Smith et al., 2015) we 
processed and analysed eosin-stained blood smear images, that gets originated from each 
of the collected sample groups. Identification of different phenotypic variations in the RBC 
population was conducted in an automated bioimage analysis tool CellProfiler™, 
(available on http://cellprofiler.org) (Carpenter et al., 2006), The CellProfiler™ offered 
methods to extract features of the cells, that uses intensity statistics likewise minimum-, 
maximum, mean-, median intensities and their standard deviation and could also extract 
different characteristic cell shape and features such as area. Applying an intelligent 
analysis software platform like the Advanced Cell Classifier (Horvath et al., 2011) (ACC, 
available on http://cellclassifier.org), we could identify and populate distinct phenotypes 
present in the populations. The automated analysis software ACC is completely based on 
the model trained techniques that could predict any given cellular phenotypic variations 
with the usage of advanced machine learning methods like active learning and neural 
networks, having minimal user interaction. The dataset analysis by ACC provided a 
detailed insight into the distribution pattern of each phenotype of interest with their 
frequency count in comparison to the control within the different study populations. 
 
Ratio of vaginal delivery /caesarean section  4:6 
Maternal age (years) 33.42 ± 4.08  
Blood sample pH 7.22 ± 0.06  
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3.3. Preparing umbilical cord and arterial cord blood samples for immunostaining 
Small portions of the dissected umbilical cord (UC) were fixed with 4% (w/v) 
paraformaldehyde in 0.05M phosphate buffer pH 7.4 (PB) and cryopreserved with 30% 
(w/v) sucrose in PB with addition of 0.1% (w/v) Na-azide. Specimen samples were 
embedded in Tissue-Tek® O.C.T.™ (Sakura Europe, 4583) and cryosectioned with a slice 
thickness of 16 µm. Further, it gets mounted on Superfrost™ ultra plus® (Thermo 
scientific, J3800AMNZ) microscope slides and kept on -80oC till further processing 
(Nishikawa et al., 2016). The whole blood derived from the cord arteries of the neonates 
was subjected to centrifuge at 200 x g for 10 min at 4°C. The lower two-thirds of the RBC 
phase was collected, washed with physiological salt solution (0.9 % NaCl, w/v), and fixed 
with 4% (w/v) paraformaldehyde in 0.05M PB at 4°C for 1hr and further processed for 
immunostaining (Cortese-Krott et al., 2012). To test the homogeneity and purity of the 
isolated RBCs, the cells were immunostained with RBC-specific marker anti-Glycophorin 
A, where the purity of the samples was > 95% for RBCs. (Chakraborty et al., 2019).  
 
3.4. Immunolabelling and image processing of the umbilical cord sections 
The umbilical cord sections were fixed and stained as per the standard protocols 
(Chakraborty et al., 2020). Slides with UC sections were withdrawn from - 80°C, thawed, 
and dried at room temperature. After consecutive washing with 0.05M PB, the sections 
were permeabilized by 0.1% Triton X-100 at room temperature for 20 min. This was 
followed by blocking the non-specific antibody binding with 4% (w/v) bovine serum 
albumin (BSA) and 5% (v/v) normal goat serum in PB. UC sections of the samples were 
immunolabelled with primary antibodies overnight at 4°C, then washed and further 
incubated with goat anti-mouse/anti-rabbit Alexa®647- or goat anti-rabbit/anti-mouse 
Alexa®488-conjugated secondary antibodies in 1:2000 dilution, for 2 h in dark at room 
temperature. Following the secondary antibody incubation step, the slides were 
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consecutively washed and counterstained with 4', 6-diamidino-2-phenylindole (DAPI) 
(D9542) from Sigma-Aldrich (St. Louis, MO, USA) in a final concentration of 1µg/ml, for 
5 min in dark. The slides were completely dried and mounted using Antifading, 
BrightMount/Plus aqueous mounting medium (Abcam, ab103748). The slides were 
visualised and images were captured under an epifluorescence microscope (Nikon Eclipse 
80i, 100x and 50x immersion objective; Nikon Zeiss Microscopy GmbH, Jena, Germany) 
with a QImaging RETIGA 4000R camera, using Capture Pro 6.0 software (QImaging, 
Surrey, BC, Canada). 
During imaging, the arteries and veins of each sample were captured at 5-10 
independent fields, resulting in at least 50 individual images of each vessel circumferences. 
Images were processed and analysed using ImageJ® software (http://imagej.nih.gov/ij/). In 
brief, the composite pictures were split into channels, corresponding to one specific 
antibody labelling. The endothelial layer was marked out by using the software-derived 
indicator tool and analysed the relevant signal particles by running a pre-recorded macro, 
which was optimized to our study protocol. The parameters were kept constant throughout 
the evaluation protocol. As a result, we saved the relevant regions of interest and projected 
it to the parent images. The mean grey values were measured, which are proportional to 
the mean fluorescent intensities (MFI) of the original images. These values were further 
corrected by subtracting the background fluorescence and quantifying five independent 
non-antibody specific fluorescent areas in each image.  
3.5. Immunohistochemistry on the isolated RBCs and analysis by florescence 
activated cell sorting (FACS)  
The isolated and fixed RBCs were washed thoroughly and permeabilized by 0.1% 
Triton X-100 at room temperature for 20 min. After permeabilization, cells were 
centrifuged at 3000 x g for 5min to discard the supernatant and consecutively washed using 
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0.05 PB. Further, RBCs were blocked for the non-specific antibody binding with 4% (w/v) 
bovine serum albumin (BSA) and 5% (v/v) normal goat serum in PB and incubated with 
primary antibodies for overnight at 4°C. This was followed by incubation with goat anti-
mouse Alexa®647 and goat anti-rabbit Alexa®488-conjugated secondary antibodies in 
1:2000 dilutions, for 2 h in dark at room temperature. Finally, RBCs were washed and 
processed for quantitative analysis (FACS, BD FACSCalibur™, BD Biosciences) 
(Mizrahi et al., 2018; Chakraborty et al., 2019). The FACS data were analysed using 
FlowJo™ (FlowJo™ Software for Windows Version 10). The antibody list used for 
immunostaining is mentioned below in Table 4. 
Antibody Host Dilution Code Distributor 
anti-Glycophorin A mouse 1:50 MA5-12484 Thermo Fisher 
Scientific, Madison, WI, 
USA 
anti-NOS3 mouse 1:100 sc-376751 Santa Cruz 
Biotechnology Inc., 





Sigma Aldrich, Saint 
Louis, Missouri, USA 
anti-Arginase1 mouse 1:100 sc-166920 Santa Cruz 
Biotechnology Inc., 
Dallas, TX, USA 
anti-NOS2 rabbit 1:100 ab3523 Abcam, Cambridge, UK 
anti 4-hydroxy-2-
nonenal (4-HNE) 
mouse 1:100 ab48506 Abcam, Cambridge, UK 
goat anti-mouse 
Alexa®647 
mouse 1:2000 ab150115 Abcam, Cambridge, UK 
goat anti-rabbit 
Alexa®488 
rabbit 1:2000 ab150077 Abcam, Cambridge, UK 
goat anti-mouse 
Alexa®488 





rabbit 1:2000 ab150079 Abcam, Cambridge, UK 
Table 4. List of the sources and dilutions of primary and secondary antibodies 
3.6. Assay for the viability of RBCs  
Arterial cord blood was collected and centrifuged at 200x g for 5 min. From the lower 
two-thirds of the RBC phase, 10 µl was diluted by 10x in 0.9% (w/v) physiological salt 
solution having pH 7.4. The diluted 1µl of the RBCs were mixed with 250µl of Annexin 
binding buffer and 2.5µl Annexin V using the Annexin V-FITC Apoptosis/Staining 
Detection kit (Abcam ab14085). The quantitative measurement was done by FACS 
(FACS, BD FACSCalibur™, BD Biosciences) (Fan et al., 2018) and all data were analysed 
using FlowJo™ (FlowJo™ Software for Windows Version 10). 
3.7. Measurement of Hydrogen Peroxide Production in the RBCs populations 
The assay was performed according to standard protocol (Villegas and Gilliland, 
1998), RBC fraction was haemolysed by the addition of distilled water at a ratio of 1 : 9. 
Spectrophotometric measurements were performed using GENESYS 10S UV–Vis 
spectrophotometer (Thermo Fischer Scientific, Madison, WI, USA). In determining the 
level of H2O2, 10x haemolysate of the samples was diluted in 50 mM PB at pH 6.0 in a 
ratio of 1:250. Serial dilutions of H2O2 between 27.5 and 440 µM were prepared and used 
as standard. Samples were incubated with 0.1% (w/v) horseradish peroxidase and 1% (w/v) 
o-dianisidine in methanol for colour development, at 37oC for 10 minutes. Reaction 
mixture without blood sample was used as blank. To stop the reaction 4N HCl is added. 
The H2O2 concentration of each sample was determined by the absorbance reading at 400 
nm and the results were calculated to a standard curve normalized with protein 
concentration (µmol/mg protein) (Gilliland and Speck, 1969). 
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3.8. Determination of the ONOO− level in the RBCs populations 
Following the ONOO−  levels, the haemolysate of each sample was diluted in 1M 
NaOH solution in a ratio of 1: 250. The spectrophotometric measurements were performed 
at 302 nm, where the increase in absorbance was considered until it reached a stable 
equilibrium. Then the samples were added into 100mM PB at neutral pH of 7.4 in the same 
ratio as the reference. At neutral pH, the ONOO− decomposes and its decrease in 
absorbance is recorded till it reaches the equilibrium point (Huie and Padmaja, 1993). 
According to Lambert-Beer’s law, the ONOO− concentration was calculated as the 
difference in the absorbance at the two distinct pH values. The final results were 
normalized with protein concentration (μmol/mg protein) (Lowry et al., 1951). 
3.9. Statistical Analysis 
All statistical analysis was considered with one-way analysis of variance (ANOVA) 
and Newman-Keuls multiple comparison test using GraphPad Statistical Software version 
6.0. The level of statistical significance was accepted at ∗p ≤ 0.05, ∗∗p ≤ 0.01, ∗∗∗p ≤ 
0.001, and ∗∗∗∗p ≤ 0.0001.   
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4. Results  
4.1. Expression of endothelial and inducible NOS and Arginase1 in the Umbilical 
Cord Vessels and the Isolated RBCs 
The pre-placental hypoxia leads to a severe intrauterine oxidative stress condition, and 
thus the NO producing NOS pathways both at the translational and phosphorylation levels 
are important for the maintenance of vasodilation. Here we followed in detail the NOS 
pathway -within the vascular cord endothelium and isolated arterial cord RBC populations 
taken from different categories of mature and premature twins in comparison to their age- 
and weight-matched singletons. 
4.1.1. Mature Non-Discordant Study Population 
UC sections originated from mature non-discordant high (Hwt) and low (Lwt) birth 
weight twins along with their age- and weight-matched singletons were immunolabelled 
in parallel with anti-NOS3/anti- phosphorylation at Ser1177 residue (pNOS3) and 
subjected to Image J© evaluation. In the endothelium of both the arteries and veins, 
originated from Hwt, as compared to their age and weight-matched controls (Hws) showed 
a significantly lowered intensity level of NOS3 and pNOS3. The NOS3 gets lowered by ~ 
25% and 50%, while the pNOS3 by ~35% and 69%, in the artery and vein, respectively 




Figure 7: Quantification of the expression of NOS3 and its phosphorylation level at 
Ser1177 residue, NOS2, and Arginase1 in the vascular endothelium and arterial cord 
RBCs of the high weight mature non-discordant twin neonates 
Mean fluorescence intensity (MFI) was expressed in percentage of NOS3 and its activated level 
pNOS3, NOS2, and Arginase1 of the mature non-discordant high birth weight (M-Hwt) N=24 twin 
neonates in comparison to their age and weight-matched singletons N=22 taken as control. The red 
dotted line represents the control intensity level at 100% within the cord vessel endothelial cells 
and isolated arterial cord RBCs. The significant differences were accepted at **** p < 0.0001 based 
on one-way ANOVA using the Newman-Keuls multiple comparison test. 
 
In the Lwt group, only the vein endothelium demonstrated a significant low level of 
NOS3 (~37%) and pNOS3 (52%) in comparison to their matching low weight singleton 
(Lws), while the artery showed no significant changes in either of the value (Figures 8). 
Based on the ratio of NOS3/pNOS3 values, the NOS3 phosphorylation status was 
somewhat increased in the vein, while remained more or less unchanged in the arteries. 





Figure 8: Estimation of the expression of NOS3 and its phosphorylation level at 
Ser1177 residue, NOS2, and Arginase1 in the vascular endothelium and arterial cord 
RBCs of the low weight mature non-discordant twin neonates 
Quantifying the MFI were expressed in percentage of NOS3 and its activated level pNOS3, NOS2, 
and Arginase1 of the mature non-discordant low birth weight (M-Lwt) N=18 twin neonates in 
comparison to their age and weight-matched singletons N=10 taken as control. The red dotted line 
represents the control intensity level at 100% within the cord vessel endothelial cells and isolated 
arterial cord RBCs. The significant differences were accepted at ***p < 0.001 and ****p < 0.0001 
based on one-way ANOVA using the Newman-Keuls multiple comparison test. 
 
The NOS3 activation pathway gets highly influenced by the Arginase1 competing for 
the common substrate L-arginine. Following the UC sections immunolabelled with 
Arginase1, showed a significant difference between the vein and arterial endothelium in 
Hwt and Lwt groups. In the Hwt artery, the Arginase1 intensity level was almost similar 
to their age -and a weight-matched singleton, whereas it is decreased by 48% in the vein 
(Figure 7). Contrastingly, the Lwt group indicated an increase of 26% in the artery and 
68% in the vein (Figure 8). The detailed representative epifluorescent images are in the 
Appendix (Figure S3 and S4). 
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Under shear stress conditions, the inducible NOS2 expression might serve as an 
alternative NO-producing pathway that increases the bioavailable NO level in the vascular 
endothelial layer. The arterial endothelium showed a significant rise in the NOS2 level 
with 98% in Hwt (Figure 7) and 122% in Lwt groups (Figure 8) in comparison to their 
matched singletons. In the Hwt vein endothelium, the NOS2 level indicated a moderate 
increase of 37% (Figure 7), while it remained unchanged in the Lwt category (Figure 8). 
The detailed representative epifluorescent images are shown in the Appendix part (Figure 
S3 and S4). 
The isolated arterial RBC populations underwent quantitative FACS analysis, 
following the NOS3 level and its phosphorylation status at Ser1177 residue. In the Hwt 
category, NOS3 was in a close match with the respective Hws (Figure 7), while there was 
a significant increase of ~53% in the Lw twins (Figure 8). The pNOS3 level highly lagged 
by ~54% in the Hwt in comparison to their matched control (Figure 7), while in the Lwt 
group a moderate increase by ~14% was measured (Figure 8). There had been an increased 
distribution of high NOS3 expressing cell population in the Hw and Lw twin neonates by 
60% and 48%, respectively but it does not state an upregulation in the NOS3 activation 
level since its phosphorylation status remained low in comparison to their age and weight-




Figure 9: FACS (Fluorescence-activated cell sorting) analysis on arterial cord RBCs 
immunolabelled with NOS3 and pNOS3 from the mature twin neonates and their 
matched singletons 
Representative histograms using FACS analysis show the NOS3 (A, C) and pNOS3 (B, D) 
intensities, respectively in the M-Hwt (blue line) and M-Lwt (red line) with their matched 
singletons (black dots). In each case, an arbitrary borderline was considered which divides the total 
RBC population into basal and high-intensity levels. 
 
Furthermore, Arginase1 expression gets upregulated in both the Hw and Lw twins by 
54.60% and 59.23%, respectively (Figure 7 and 8) along with a significant increase in the 
frequency of high Arginase1 expressing cells population i.e. 86% in Hwt and 67% in the 




Figure 10: Evaluation of FACS analysis on the Arginase1 immunolabelled arterial 
cord RBCs 
Panels (A, B) show representative histogram plots as measured by the FACS analysis using anti-
Arginase1 primary antibodies on the foetal arterial cord RBCs derived from the mature twin 
neonates and their matched singletons respectively. In the control and twin samples, an arbitrary 
borderline was considered along the x-axis dividing the total RBC population into basal and high 
Arginase1 expressing cells. The graphical representation in the (C) panel indicates the frequency 
of high Arginase1 expressing RBC population from M-Hwt (N=24) vs M-Hws (N=22) and M-Lwt 
(N=18) vs M-Lws (N=10). The statistical significance was accepted at ****p<0.0001 based on 
one-way ANOVA using the Newman-Keuls multiple comparison test. 
 
4.1.2. Premature Non-Discordant Study Population 
Here the preterm non-discordant high birth weight twin neonates were compared to 
their age- and weight-matched singletons and age-matched twin pairs born with low birth 
weight. The UC sections were immunolabelled with anti-NOS3/anti-pNOS3. The cord 
arterial endothelium of the Hwt showed a significant increase in the NOS3 expression and 
its phosphorylation intensity level by ~13% and ~17% respectively in comparison to their 
age – and weight-matched singletons (Hws). In this vein, both the values of NOS3 and 




Figure 11: Estimation of the expression of NOS3 and phosphorylated NOS3, NOS2, 
and Arginase1 in the vascular endothelium and arterial cord RBCs of the high weight 
preterm twin neonates 
Mean fluorescence intensity was expressed in percentage of NOS3 and its activated level i.e. 
phosphorylated NOS3 (pNOS3), NOS2, and Arginase1 of the preterm non-discordant high birth 
weight twin neonates (Pr-Hwt) N=20 in comparison to their age and weight-matched singletons 
(Pr-Hws) N=15 taken as control. The red dotted line represents the control intensity level at 100% 
within the cord vessel endothelial cells and isolated arterial cord RBCs. The significant differences 
were accepted at **p < 0.01, ***p < 0.001 and ****p < 0.0001 based on one-way ANOVA using 
the Newman-Keuls multiple comparison test. 
 
The comparison between the Hw versus Lw twin populations indicated that the NOS3 
expression in the Lwt arteries to some extent remained behind the Hwt values (~28%) with 
about the same phosphorylation intensity level. The NOS3 expression in the Lw vein 
stayed unaltered with a significant increase by ~26% in the pNOS3 intensity level (Figure 






Figure 12: Quantification of the expression of NOS3 and phosphorylated NOS3, 
NOS2, and Arginase1 in the vascular endothelium and arterial cord RBCs of the low 
weight preterm twin neonates 
Estimation of the MFI was expressed in percentage of NOS3, phosphorylated NOS3, NOS2, and 
Arginase1 of the preterm non-discordant low birth weight (Pr-Lwt) N=12 twin neonates in 
comparison to their high weight twin group (Pr-Hwt) N=20 taken as control. The red dotted line 
represents the control intensity level at 100% within the cord vascular endothelial cells and isolated 
arterial cord RBCs. The significant differences were accepted at ****p < 0.0001 based on one-way 
ANOVA using the Newman-Keuls multiple comparison test. 
 
As a consequence, the phosphorylation status of NOS3 gets upregulated in both the 
vessels of Lwt in comparison to the Hwt group. Considering the role of Arginase1, being 
a critical modulator of NOS3 we find that the Arginase1 expression is elevated 
significantly in both the arteries and veins of the Hw twins by ~85% and ~30%, 
respectively in comparison to the Hws (Figure 11). In correlation, with the Lwt and Hwt 
populations, there was a ~22% increase in the Arginase1 expression within the Lw arteries 
while no significant difference was detectable in the veins (Figure 12). 
Upregulation of NOS2 might be an important biomarker that can maintain the 
bioavailable NO level in the vascular endothelial layer under shear stress conditions. The 
age -and weight-matched singleton versus Hwt indicated no significant difference in the 
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NOS2 expression for any of the cord vessels (Figure 11). In the case of Lwt in comparison 
to Hwt samples, the NOS2 expression was significantly higher in the Lwt arteries ~ 47%, 
while there were no detectable changes in the vein (Figure 12). The detailed representative 
epifluorescent images are in the Appendix part (Figure S7 and S8). 
Following the NOS3 and pNOS3 intensity level by FACS analysis in the isolated 
arterial RBC population, the Hwt in comparison to Hws showed an elevated expression of 
NOS3 by ~ 73.64% and almost ~ 206.35% higher NOS3 phosphorylation intensity level 
(Figure 11 and 13). While in between the Hw and Lw twin neonates there lies no significant 
variation in the NOS3 and phosphorylated NOS3 intensity values (Figure 12 and 13).  
 
Figure 13: FACS analysis on NOS3 and pNOS3 immunolabelled foetal RBC 
populations originated from preterm, non-discordant twin and matched singleton 
neonates 
Representative histograms (A, B) showing NOS3 and pNOS3 intensity levels in preterm, high 
weight twin (Pr-Hwt, blue line) in comparison with their age and weight-matched singleton (Pr-
Hws, orange dots). Similarly, histograms (C, D) represent the comparison between Pr-Hwt (blue 
dots) with low weight (Pr-Lwt, red line) twin samples. In each case, an arbitrary borderline was 
considered dividing the total RBC population into basal and high-intensity levels. 
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The expression of Arginase1 in the isolated RBCs via FACS analysis clearly indicated 
an elevation by 48% in the Hwt to their age and weight-matched singletons (Figure 11 and 
14), while in the Hwt versus Lwt group there was no significant difference in Arginase1 
expression level (Figure 12 and 14). 
 
Figure 14: FACS analysis on RBC populations, immunolabelled with Arginase1  
Representative histograms as measured by the FACS analysis using anti-Arginase1 primary 
antibodies showed in panel (A) the comparison between foetal RBCs derived from preterm, non - 
discordant high weight twin (Pr-Hwt, blue line) with their age-matched high weight singleton (Pr-
Hws, orange line) and (B) presents the comparison between Pr-Hwt and low weight (Pr-Lwt, red 
line) twin sample. For each control and twin sample, an arbitrary borderline was considered along 
the x-axis dividing the total RBC population into basal and high expressing cells. The graphical 
plot (C) indicates the frequency of high Arginase1 expressing RBC populations in the preterm, 
non-discordant twin neonates (Pr-Hwt-N=20; Pr-Lwt-N=12) and age -weight-matched singletons 
(Pr-Hws-N=15). The statistical significance was accepted at ****p<0.0001 based on one-way 
ANOVA using the Newman-Keuls multiple comparison test. 
 
4.1.3. Premature Discordant Study Population 
The NOS3 activation pathway was followed in twin siblings, born with high birth 
weight differences i.e. more than 25%. 
The UC sections derived from the discordant preterm twin pairs were immunostained and 
subjected to Image J© evaluation. The NOS3 expression and its phosphorylated level of 
the Lw neonates significantly lag behind in comparison to their high weight siblings; in 
the artery by 37% and 45%, while in the vein ~19% and ~26%, respectively (Figure 15). 
The detailed representative epifluorescent images of the vascular endothelium are 
51 
 
described in Appendix (Figure S9 and S10). As a result, the phosphorylation status of 
NOS3 was low in both the vessels of the Lw-siblings originated from the discordant twin 
pair.  
 
Figure 15: Estimation of the expression of NOS3 and activated pNOS3, NOS2, and 
Arginase1 in the vascular endothelium and arterial cord RBCs between the 
premature discordant twin pair 
Quantification of the MFI was expressed in percentage of NOS3, phosphorylated NOS3, NOS2, 
and Arginase1 of the preterm discordant low birth weight twin neonates (N=20) in comparison to 
their high weight twin pair (N=20), considered as control. The red dotted line represents the control 
intensity level at 100% within the cord vascular endothelial cells and isolated arterial cord RBCs. 
Statistical significances were accepted at *p < 0.05, **p < 0.01, ***p < 0.001 and ****p < 0.0001 
based on one-way ANOVA using the Newman-Keuls multiple comparison test. 
We know in the NOS3 regulation pathway the expression of Arginase1 plays a very 
vital role. Here we find that the Arginase1 expression in the Lw-neonates is significantly 
lower in both the arteries and vein by ~17-18% compared to their siblings (Figure 15). 
Whereas, the NOS2 being an alternative source for bioavailable NO, was present at a much 
higher level in the cord arterial endothelium of the low weight siblings to almost ~24%, 
while in the vein it was significantly lowered by ~37% (Figure 15). The detailed 
representative epifluorescent images are in the Appendix section (Figure S11 and S12). 
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In parallel, isolated cord arterial RBCs were immunostained for FACS analysis. No 
significant difference was detected in the NOS3 expression and frequency of the high 
NOS3 expressing cells between the discordant twin pairs (Figure 15 and 16).  
 
Figure 16: FACS analysis on foetal RBC populations originated from preterm, 
discordant twin neonates, immunolabelled with NOS3 and pNOS3 
FACS analysis on foetal RBCs from preterm, discordant twin siblings, immunolabelled with anti-
NOS3 and anti-pNOS3. The representative histograms (A, B) using FACS analysis show the NOS3 
and pNOS3 intensity levels in preterm, high weight (PrD-Hw twin, blue line) and low weight twin 
samples (PrD-Lwt, red line) respectively. The graphical representation (C) exhibits the frequency 
of high NOS3 expressing cell population derived from preterm discordant twins where N=20 pairs. 
 
However, we find that the pNOS3 intensity level was significantly higher in the low 
weight neonates by ~29% (Figure 15), as a result, the phosphorylated status of NOS3 





Figure 17: Illustration of MFI on the NOS3 expression and its phosphorylated level 
(pNOS3) in the foetal RBC populations  
The graphical plot illustrates the MFI of NOS3 expression and its activation/phosphorylated level 
at Ser1177 residue in the foetal RBCs, derived from preterm, discordant twin neonates. The 
significant differences were accepted at *p< 0.05 based on one-way ANOVA using the Newman-
Keuls multiple comparison test. 
 
The Lw siblings show a significantly higher level of Arginase1 expression to almost 
~33% (Figure 15 and 18) due to increased distribution of high Arginase1 expressing cell 








Figure 18: FACS analysis on foetal RBC populations from preterm, discordant twin 
neonates, immunolabelled with Arginase1 
Representative histogram plot (A) and the graphical representation (B) presents the intensity level 
and the frequency of high expressing Arginase1cell population respectively by the FACS analysis 
using anti-Arginase1 primary antibodies on foetal RBCs originated from the arterial cord of 
preterm, discordant high weight (PrD-Hwt, blue dot) and low weight (PrD-Lwt, red line) twin 
siblings where N=20 pairs. For each control and twin sample, an arbitrary borderline was 
considered along the x-axis dividing the total RBC population into basal and high expressing cells. 
The statistical significance was accepted at ****p<0.0001 based on one-way ANOVA using the 
Newman-Keuls multiple comparison test. 
 
4.2. Quantitative estimation of lipid peroxidation, determined by the 4-
Hydroxynonenal level and Annexin V positive population in the UC vessels and the 
isolated RBCs 
Due to the overproduction of ROS, the rate of lipid peroxidation gets enhanced. The 
most common products formed are the oxygenated α, β-unsaturated aldehydes such as 4-
hydroxynonenal (4-HNE). The formation of this aldehyde was followed by 
immunolabelling the aldehyde-protein adduct with an anti-4-HNE antibody. Furthermore, 
due to the excess rate of lipid peroxidation, the level of phosphatidylserine gets altered in 
the outer leaflet of RBC plasma membranes which is easily detected by Annexin V and 
quantified using FACS analysis. 
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4.2.1. Mature Non-Discordant Study Population 
Measurement of the 4-HNE intensity level in the cord vessels’ endothelium, indicated 
a significant increase in the arteries of Hwt (~65%) and Lwt (~214%) neonates. The vein 
endothelium showed a moderate increase of 20% in Hw and 33% in Lw twin population 
in comparison to their age and weight-matched singletons (Figure 19 A-B). The detailed 
representative epifluorescent images are mentioned in the Appendix (Figure S3 and S4). 
 
Figure 19: Quantification of the 4-HNE level in the vascular endothelium and arterial 
cord RBCs of the mature non-discordant twin neonates 
Panels (A-B) indicate the MFI value in percentage of the 4-HNE level in M-Hwt (N=24) vs M-
Hws (N=22) and M-Lwt (N=18) vs M-Lws (N=10) respectively. The red dotted line represents the 
control (i.e. age and weight-matched singletons) intensity level at 100% within the cord vessel 
endothelial cells and isolated arterial cord RBCs. The significant differences were accepted at ***p 
< 0.001 and ****p < 0.0001 based on one-way ANOVA using the Newman-Keuls multiple 
comparison test. 
 
The arterial cord isolated RBCs were considered for FACS analysis to estimate the 4-
HNE intensity level and Annexin V positive population. The 4-HNE intensity level gets 
prominently increased in both the twin groups irrespective of their birth weight (Figure 19 
A-B and 20), which highly correlates with the increased frequency of high 4-HNE 





Figure 20: Evaluation of the immunolabelled 4-HNE level on the arterial cord RBCs 
by FACS analysis 
Panels (A-B) show the representative histogram plots as measured by the FACS analysis using 
anti-4-HNE primary antibody on the foetal arterial cord RBCs derived from M-Hwt (blue line) and 
M-Lwt (red line) with their matched singletons (black dots) respectively. For each control and twin 
sample, an arbitrary borderline was considered along the x-axis dividing the total RBC population 
into basal and high 4-HNE expressing cells. The graphical representation in the (C) panel indicates 
the frequency of high expressing 4-HNE levels in the RBC population of the mature Hw (N=24) 
and Lw (N=18) twin neonates compared to their age-matched Hw (N=22) and Lw (N=10) 
singletons. The statistical significance was accepted at ****p<0.0001 based on one-way ANOVA 
using the Newman-Keuls multiple comparison test.  
Again, the isolated RBCs, derived from the age –and weight-matched singletons and 
twin groups were commonly stained by Annexin V, which indicates the level of 
phosphatidylserine in the outer leaflet of RBC plasma membranes. The distribution of 
Annexin V positive population is significantly higher by ~19% and ~27% in the Hw and 




Figure 21: Viability assay on isolated RBCs by the FITC-conjugated Annexin V 
Viability assay on isolated RBCs by the FITC (Fluorescein IsoThioCyanate) –conjugated Annexin 
V. Panel (A–D) are representative zebra plots derived from isolated RBCs of the age and weight-
matched M-Hws (N=12), M-Hwt (N=15), M-Lws (N=8) and M-Lwt (N=11), respectively. For 
control and twin samples, an arbitrary borderline was considered along the x-axis, where the Q3 
quadrant represents the AnnexinV positive cells. The graphical summary (E) shows the percentage 
distribution of AnnexinV positive RBCs localized in Q3 quadrant. Statistical significance was 
accepted at ****p<0.0001 using the Newman-Keuls multiple comparison test. 
 
4.2.2. Premature Non-Discordant Study Population 
Here the intensity levels of 4-HNE as evaluated by Image J©, in the cord arteries of 
the Hw twin neonates, showed a significant increase of ~31% with no alterations in the 
vein as compared to their age -and weight-matched singletons. In the Hwt versus Lwt 
group, the values significantly increased to ~17% in the arterial endothelium while the 
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intensity level remained unchanged. in the veins (Figure 22 A-B). The detailed 
representative epifluorescent images are mentioned in the Appendix (Figure S7 and S8).  
 
Figure 22: Quantification of the 4-HNE level in the vascular endothelium and arterial 
cord RBCs of the premature non-discordant twin neonates 
Graphical illustration in panels (A-B) indicates the MFI values in percentage of the 4-HNE level 
in the preterm non-discordant Hw (A; N=20) and Lw (B; N=12), twin neonates, in comparison to 
age and weight-matched singletons (A; N=15) and Pr-Hwt (B; N=20) respectively, taken as control. 
The red dotted line represents the control intensity level at 100% within the cord vessel endothelial 
cells and isolated arterial cord RBCs. The significant differences were accepted at **p < 0.01 and 
****p < 0.0001 based on one-way ANOVA using the Newman-Keuls multiple comparison test. 
 
The isolated RBCs by FACS analysis exhibited an up rise to ~108% in the Hwt when 
compared to the age-matched singleton group. The Lwt neonates in comparison to Hwt 







Figure 23: FACS analysis on RBC populations, immunolabelled with 4-HNE  
Representative histograms as measured by the FACS analysis using anti-4 HNE primary antibodies 
showed in panel (A) the comparison between foetal RBCs derived from preterm non-discordant 
high weight twin (Pr-Hwt, blue line) and age-matched high weight singleton (Pr-Hws, orange line) 
and (B) present the comparison between Pr-Hwt and low weight (Pr-Lwt, red line) twin sample. 
For each, control and twin sample, an arbitrary borderline was considered along the x-axis dividing 
the total RBC population into basal and high expressing cells. The graphical plot (C) indicates the 
frequency of high 4-HNE expressing RBC populations in the preterm, non-discordant Hw (N= 20) 
and Lw (N=12) twin neonates and age-weight matched singletons (Pr-Hws; N=15). The statistical 
significance was accepted at ****p<0.0001 based on one-way ANOVA using the Newman-Keuls 
multiple comparison test. 
 
In parallel, RBC populations were stained with Annexin V and revealed an elevated 
frequency of ~ 12.5% in the Annexin V positive RBCs originated from Hwt in comparison 
to the Hws populations. However, no significant difference existed between the Hwt and 




Figure 24: Viability Assay on the isolated arterial cord RBCs derived from preterm 
non-discordant twin siblings 
Representative panels (A, B) and (C, D) of zebra plots showed the isolated RBCs of the premature 
Hwt (N=15) with their age and weight-matched singletons Hws (N=10), and Pr- Hwt (N=15) in 
comparison to their non-discordant Lwt (N=12) group respectively that are treated with FITC 
(Fluorescein IsoThioCyanate) - conjugated Annexin V. For control and twin samples, an arbitrary 
borderline was considered along the x-axis, where the Q3 quadrant represents the Annexin V 
positive cells. The graphical summary (E) shows the percentage distribution of Annexin V positive 
RBCs localized in the Q3 quadrant. **** Marks the significant differences based on the Newman-
Keuls multiple comparison test at p < 0.0001. 
 
4.2.3. Premature Discordant Study Population 
In the discordant twin population, the low birthweight siblings exhibited a significant 
increase of the 4 HNE level in the cord arteries and vein by ~42% and ~25%, respectively 
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(Figure 25) and detailed representative epifluorescent images are in the Appendix section 
(Figure S11 and S12).  
 
Figure 25: Measurement of the 4-HNE level in the vascular endothelium and arterial 
cord RBCs of the premature discordant twin neonates 
The MFI of the 4-HNE level in the preterm discordant low birthweight siblings was expressed as 
a percentage in comparison to their high weight twin pair, considered as control. The red dotted 
line represents the control intensity level at 100% within the cord vascular endothelial cells and 
isolated arterial cord RBCs. Statistical significances were accepted at ***p < 0.001 and ****p < 
0.0001 based on one-way ANOVA using the Newman-Keuls multiple comparison test. 
The FACS analysis on the isolated cord arterial RBCs also indicated an upsurge by 69% 
in the HNE intensity level of the Lwt category in comparison to their Hw siblings (Figure 





Figure 26: FACS analysis on foetal RBC populations from preterm, discordant twin 
neonates, immunolabelled with 4-HNE 
Representative histogram plot (A) and the graphical representation (B) measures the intensity level 
and the frequency of high expressing 4-HNE cell population respectively by the FACS analysis 
using anti-HNE primary antibodies on foetal RBCs originated from the arterial cord of preterm, 
discordant high weight (PrD-Hwt; N=20, blue dot) and low weight (PrD-Lwt; N=20, red line) 
siblings. For each control and twin sample, an arbitrary borderline was considered along the x-axis 
dividing the total RBC population into basal and high expressing cells. The statistical significance 
was accepted at ****p<0.0001 based on one-way ANOVA using the Newman-Keuls multiple 
comparison test. 
Further to test the Annexin V positivity, RBCs from the discordant twin pairs were 
subjected to FACS, where a significant increase in the frequency of Annexin V positive 






Figure 27: Viability Assay on the isolated arterial cord RBCs derived from the 
preterm discordant twin pairs 
Panel (A and B) represents the zebra plots of the isolated arterial cord RBCs derived from preterm 
discordant twin N=20 pairs that are treated with FITC (Fluorescein IsoThioCyanate) - conjugated 
Annexin V. In the control and twin sample, an arbitrary borderline was considered along the x-
axis, where the Q3 quadrant represents the AnnexinV positive cells. The graphical summary (C) 
shows the percentage distribution of Annexin V positive RBCs localized in the Q3 quadrant. 
Statistical significance was accepted at **** p < 0.0001 using the Newman-Keuls multiple 
comparison test.  
 
4.3. Analysis of phenotypical variants in RBCs 
In a preliminary platform increased frequency of different phenotypical variants in the 
RBC population can be an indication of various kinds of clinical disorders. Altogether, we 
screened over ~ 3000 RBCs from the singletons, ~ 2000 from the mature, and 4000 from 
the premature twin origins. We specifically looked for Burr cells, Elliptocytes, and 
Rouleaux phenotypes beside the regular healthy biconcave-shaped RBCs. There was no 
major significant alteration in the frequency of morphological variants between the mature 
and premature singleton groups. However, a significant difference was found between the 
singletons and twin neonates from mature and premature origins. In the mature twins, 3-
fold and premature twin group 2-fold increase had occurred in the Burr cells type of the 
RBC population. It was almost negligible to identify Elliptocytes and Rouleaux variants in 
the singletons. The premature in comparison to the mature twin populations, demonstrated 
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~ 2 to 2.5-fold increase in the Elliptocytes and a ~5-fold increase in the Rouleaux 
phenotypes, irrespective of their birth weight (Figure 28). 
 
 
Figure 28: Distribution of morphological variants of RBCs derived from mature and 
premature twin siblings 
The distribution of morphological variants in the isolated RBCs derived from singletons in 
comparison to mature and premature twin populations were analysed by the Advanced Cell 
Classifier software. Screening of RBCs (N=600 cells/sample) were counted from both singleton 
and twin origin. Statistical significance in the frequencies of the regular Biconcave at (*** p < 
0.001), Burr at (*** p < 0.001 and **** p < 0.0001), Elliptocytes at (**** p < 0.0001 and ** p < 
0.01) and Rouleaux at (**** p < 0.0001) were accepted by one-way ANOVA using the Newman-
Keuls multiple comparison test. 
 
4.4. Spectrophotometric measurement of H2O2 and ONOO− levels in the RBCs 
RBCs originated from different mature and premature origins, mostly undergo a 
higher level of cellular oxidative stress condition. Here we see that irrespective of their 
birthweight differences the deleterious oxidant level of ONOO− was significantly 
increased by ~ 2.- 2.5 fold in the mature and ~1.5- 2 fold in the premature twin neonates 
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in comparison to the singletons. This was in good correlation with the significant rise of 
another strong oxidant, the H2O2 level by ~1.3-fold in the mature and ~1.7-fold in the 
premature twins, which further indicated an imbalance between the endogenous oxidant 
and antioxidant system (Figure 29). 
 
Figure 29: Spectrophotometric measurements of the strong oxidants in the isolated 
RBCs derived from twin origin 
Estimation of the hydrogen peroxide (H2O2) and peroxynitrite (ONOO¯) levels were measured by 
spectrophotometric methods in the isolated arterial cord RBCs from singleton (N=14), mature 
(N=12 pairs) and premature (N=15 pairs) twin origin. Statistical significance was accepted at * p 
< 0.05, ** p < 0.01, *** p < 0.001 and **** p < 0.0001 by one-way ANOVA using the Newman-





There had been increasing evidence that indicates towards enhanced rate of oxidative 
insults during intrauterine development and variedly contributes to the occurrence of 
pathological conditions in post-natal or adult life. An adverse intrauterine environment 
develops in all clinical cases of multiple/twin pregnancy, pre-eclampsia, ectopic 
pregnancy, and intrauterine growth restriction that gets directly or indirectly associated 
with placental or umbilical cord disorders (Ávila et al., 2015; Argyraki et al., 2019). In 
comparison between singleton and twin or multiple pregnancies, there always exists an 
additional oxidative stress condition due to long-term intrauterine hypoxia and causes 
impaired blood flow to the feto vascular system (Al-Gubory et al., 2010; Acharya et al., 
2016; Rodríguez-Rodríguez et al., 2018).  
At early stages of an in-utero development until late in the third trimester, along with 
the presence of low immunocompetence prevails a partially developed endogenous or 
passively acquired exogenous antioxidant system (Georgeson et al., 2002; Davis and 
Auten, 2010; Perrone et al., 2010, 2019). Specifically, in cases of preterm birth, the 
antioxidant system is not fully developed and gets associated with an increased oxidant 
burden which places these neonates at a much higher risk of injury. Thereby, any altered 
physiological and metabolic functions in the developing foetus can easily disrupt the 
delicate balance between ROS and their intrinsic antioxidant defense system. This shifting 
in the redox homeostasis increases oxidative stress and eventually predisposes to severe 
obstetric complications like birth asphyxia, respiratory disorders, prematurity, structural 
abnormalities, delayed development, and most commonly low birthweight (Thaete et al., 
2004; Hayes, 2005; Buonocore and Perrone, 2009; Su et al., 2015). 
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During long-term oxidative stress conditions like twin pregnancy, mapping the 
efficacy of the NOS pathway becomes pivotal in the regulation of bioavailable NO for 
vasorelaxation and free flow of blood supply within the cord vascular system. Previously, 
our working group pioneered in demonstrating an increased ROS production and 
compromised antioxidant system in parallel with the increased level of NOS3, leading to 
elevated macromolecular damage in the foetal RBCs of the twin neonates (Dugmonits et 
al., 2016). Therefore, now in a detailed comparative study, we attempted to elucidate the 
significance of intimate crosstalk in between the foetal RBCs and the cord vascular 
endothelium that involves the signalling pathway of NOS3 activation. Our results clearly 
highlighted the morphological alterations, functional and physico-chemical changes 
parallelly in both the cord-derived RBCs and vascular cord endothelium of twin neonates. 
Here we selected both mature and premature twin populations with a wide range of 
differences in the birth weights, along with their respective age and weight-matched 
singletons. The NOS3 expression and its activation in the cord vessels and circulating 
RBCs of the selected study populations show different statuses, with a high correlation to 
the neonatal birthweights. 
In the mature high-weight twin category, the NOS3 expression and its activation gets 
somewhat impaired both in the cord vessels and the circulating foetal RBCs compared to 
weight and age-matched singletons. In the mature low weight non-discordant category, the 
NOS3 expression dropped drastically only in the cord vein, however, its phosphorylation 
at Ser1177 position increased, as a compensatory attempt to increase NO production. 
Similarly, as part of the rescue mechanisms elevated NOS3 expression was observed in 
red blood cells.  
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In the preterm twin population, the NOS3 regulation in the cord vessels remains almost 
undisturbed in both the Hwt and Lwt neonates. Moreover, their RBC population shows 
responsiveness to the intrinsic oxidative stress status and works as a rescue mechanism by 
the upregulation of the RBC-NOS3-NO pathway. Their elevated expression and 
phosphorylation levels signify an effort to improve blood flow in UC vessels, however, 
this capacity of the foetal RBCs decreases, as pregnancy progresses. Based on our data set, 
in most of the selected categories (with an exception for the Pr-Hwt) the UC vessels along 
with the RBCs, could not suffice to maintain the desired NO level, and thus another 
alternative NO producing pathway gets induced, the NOS2, in the arterial endothelium. 
Particularly, the lower-weight siblings from the discordant twin population showed an 
upregulated arterial NOS2 system along with the functional RBC-NOS3-NO pathway as a 
part of the rescue mechanisms. Initially, even a moderate increase in the NOS2 expression 
could sufficiently increase the NO level, regarding the higher rate of NOS2 catalytic 
activity i.e. (100-1000 fold that of the NOS3 (Ratovitski et al., 1999). Though at first, 
NOS2 upregulation seems to be beneficial by providing an alternative source for the 
bioavailable NO, the higher rate of its catalytic activity adds to ROS elevation and induced 
cell apoptosis through caspase-3 activation (Geng et al., 1996; Liu et al., 2002). Thus an 
elevated NOS2 level exhibits a pro-inflammatory profile and gets associated with 
pathological conditions like inflammation, sepsis, or oxidative stress (Kleinert et al., 2010) 
causing macromolecular damages in the vascular endothelium.  
One of the major key steps in the NOS3 pathway is the coupling of NOS3 and dimer 
formation, which gets activated by phosphorylation at serine 1177 residue to liberate the 
bioavailable NO (Shu et al., 2015b). Arginase1 being a competitive inhibitor of NOS3 for 
common substrate L-arginine steals away the common substrate which inhibits the 
coupling and activation of NOS3. Imbalance in redox homeostasis generates excessive 
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ROS which further catalyses the upregulation of Arginase1 expression and activity by 
tightly regulating the NOS3 pathway, producing reactive species like O2
•– instead of the 
bioavailable NO and L-citrulline. The limited amount of bioavailable NO in the system 
readily reacts with O2
•– and instantaneously form deleterious pro-oxidant entities like 
ONOO– showing the “Janus faced” role of NO (Förstermann, 2006; Yu et al., 2018).  
In general, Arginase1 influences the vascular function with the production of L-
ornithine as its active metabolite but an excessive synthesis of polyamine and proline from 
L-ornithine also plays a pivotal role in pathological vascular remodelling, endothelial and 
smooth muscle cell proliferation, and collagen deposition (Yang and Ming, 2013; Lucas et 
al., 2014). In the mature non-discordant Hwt and Lwt groups, there was a major rise in the 
Arginase1 expression in the vascular endothelium and further even gets doubled in the 
RBC populations to their age and weight-matched singletons. As a sequel of this harmful 
consequence, it shows a strong impact on the functionality of the RBC-NOS NO pathway. 
In connection to the preterm birth, here the Arginase1 expression is also highly upregulated 
in the vascular endothelium of the non-discordant twins but gets significantly reduced in 
the Lw siblings from the discordant origin. Though in the case of premature twinning, we 
find a significant increase of Arginase1 expression in the foetal cord RBCs, still then the 
RBC-NOS3-NO pathway was activated, both at the translational and phosphorylation 
levels. The foetal RBCs retained their competency to show the compensatory mechanism 
under acute oxidative stress conditions. An elevated Arginase1 expression signifies the 
excessive generation of ROS and simultaneously has an impact on the NOS3 –NO pathway 
not only in the circulating RBCs but also in the vascular endothelium. In the mature twin 
population as well as in the case of neonates born to smoking mothers the high Arginase 
level always implies a drastic reduction in the bioavailable NO, exclusively due to an 
impaired NOS3-NO pathway both in the UC vessels and the circulating foetal RBCs. This 
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consequently causes indiscriminate macromolecular damages and aggravates ED 
(Dugmonits et al., 2019; Chakraborty et al., 2020; Zahorán et al., 2021). Moreover taking 
into account the intimate communication between the circulating RBCs and the 
endothelium, the enhanced Arginase1 level or its activity in the circulating RBCs are well 
implicated in various cardiovascular disorders and other pathological states like the Type 
2 diabetes mellitus (Yang et al., 2013; Zhou et al., 2018b; Pernow et al., 2019a). However, 
the direct correlation between Arginase1 expression and NOS3 activation for their 
competition to the common substrate L-arginine becomes complicated with the emerging 
paradox that states L-arginine concentrations in endothelial cells remain sufficiently high 
to support NO synthesis on the approach of compartmentalization of intracellular L-
arginine into distinct, poorly interchangeable pools (Elms et al., 2013). However, apart 
from other cell types, RBCs hold a unique cytoskeletal structure and are devoid of major 
intracellular organelles where the chances of intracellular L-arginine compartmentalization 
into distinct interchangeable pools becomes negligible.  
Finally, with an alteration in the NOS3 functionality, following the extent of 
macromolecular damages in the vascular endothelium and the foetal circulating RBCs, we 
find a significant rise in the 4-HNE level. The 4-HNE level as an indicator of the rate of 
lipid peroxidation was highly marked irrespective of maturity and birth weight differences 
in the twin population. Moreover, it is also shown that due to the greater extent of lipid 
peroxidation in the predominant circulating foetal RBCs, the RBC lipid bilayer membrane 
characteristics gets altered with an increased loss in their membrane integrity and 
properties as similar to neonates derived from sustained maternal smoking (Balogh et al., 
2020a). Therefore, the molecular alterations affecting the membrane cytoskeletal system 
in the RBCs as supported by the significant increase in the Annexin V positive RBCs 
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implies the altered RBC membrane asymmetry, membrane damage, and loss of functional 
properties in the twin neonates.  
It is noteworthy to mention that the neonatal RBCs get functionally impaired far ahead 
of any detectable morphological aberrations as implied in the case of neonates derived 
from the smoking origin (Dugmonits et al., 2019). Further, a detailed survey on the 
phenotypic variants of RBCs always served as a preliminary platform for many clinical 
diagnoses (Mohandas and Gallagher, 2009). Studying the morphological variants in the 
mature and premature twin RBC populations we exhibited a significant rise of burr cell 
phenotype in the RBC morphology similar to the neonates derived from smoking origin 
which mainly occurs due to disproportionate distribution of fatty acids, lysophospholipids 
in the lipid bilayer of the RBC membrane (Gallagher, 2005; Dugmonits et al., 2019; Balogh 
et al., 2020b). In addition, specifically in the preterm twin category, we cited a significant 
distribution of elliptocytes and rouleaux phenotype. Literature reviews clinically suggest 
morphological differentiation of elliptocytes indicate iron deficiency and megaloblastic 
anaemia whereas RBC aggregates like rouleaux formation result due to high fibrinogen 
level causing lower blood flow rates that might lead to pathogenesis of circulatory and 
thromboembolic complications in clinical cases like septicaemia, pregnancy, diabetes, etc. 
(Linderkamp et al., 1984; Ford, 2013; Bosman, 2018).  
Thus citing the detectable phenotypical variants of RBCs due to possible changes in 
their cytoskeletal network of the mature and premature twin pairs as compared to 
singletons would definitely recognize and intervene into the possible complications at 
earlier stages of theirs post-natal or adult life (Pretorius et al., 2013; Soma and Pretorius, 
2015; Masilamani et al., 2016; Diederich et al., 2018). Here we have no supporting data 
that states any direct correlation between these phenotypical changes with their altered 
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functionality, which can be marked as a limitation to our conclusion. However, the 
functional alteration of NOS3/pNOS3 status in the circulating RBCs within twin origin at 
different maturity levels could be a real-time sensor for the possible adverse outcomes in 





Overall, understanding the basic pathophysiological mechanisms in neonatal diseases 
necessitates a detailed knowledge about the wide range of complications that includes all 
three major constituents of the feto-vascular system (RBCs, arteries, and veins). Both the 
endothelial cells of UC vessels and the RBCs separately contribute to the NO metabolism, 
vascular function, systemic hemodynamics, and blood pressure homeostasis via NOS3. 
Based on our data set we see a different pattern of cellular stress regulation in between 
the different maturity levels of the twin population. Comparing our data sets on premature 
twins it is completely vivid now that the NOS3-activation capacity of the cord vessels and 
foetal RBCs are far more efficient than in the case of the mature twin population or in 
neonates, born to smoking mothers. Irrespective of a common, highly hypoxic 
environment that characterizes the premature or mature twin pregnancies and maternal 
smoking-induced conditions in the neonates, the mediated oxidative stress response is 
based on the distinguishable level of Arginase1. There shows clear evidence of intimate 
crosstalk in between the RBCs and the vascular endothelium where the Arginase-
dependent alterations in the RBC-NOS pathway seem to be a determining factor for the 
further development of ED in the vascular system. As during the progressive pregnancy 
period there occur rapid physiological and metabolic changes, thus it becomes an essential 
factor to map the NOS3 signalling pathway at different time points of gestation. 
Furthermore, from the clinical point of view under adverse intrauterine conditions 
monitoring the Arginase level might well serve as a prognostic marker to track the overall 





I would like to first express my extended gratitude and thanks to my supervisor Dr. 
Edit Hermesz, for giving me the opportunity to work on this very exciting project, and 
sharing with me all the necessary knowledge, laboratory space and equipment to conduct 
my PhD work.  
I am greatly thankful to Prof. Csaba Vágvölgyi, as Head of the Doctoral School of Biology 
for giving me scope to work in the Department of Biochemistry and Molecular Biology at 
the Institute of Biology, University of Szeged. I was always inspired by his personality and 
be grateful for his extensive support over the years of my PhD work. Similarly, I am also 
grateful to Prof. Boros Imre for his encouraging words and motivational interactions with 
me about my research. I also like to thank Dr. László Bodai, the Head of the Department 
of Biochemistry and Molecular Biology to be supportive and give me the scope to work 
and utilize all the necessary instruments of the department during my research work.  
I am especially thankful to our collaborator, Dr. Hajnalka Orvos, for arranging the 
clinical samples to conduct the experiments from Department of Gynecology and 
Obstetrics at the University of Szeged. My journey of PhD also remains incomplete 
without the kind help and co-operation from all my lab members, I heartedly thank and 
acknowledge Dr Ágnes Ferencz, Dr Krisztina Dugmonits, Ali Khamit and Dr Szabolcs 
Zahorán. I am also thankful to our administrative and academic staff members of the 
department who remained as an excellent support system to carry out my PhD work in 
Szeged.  
I owe a lot to the funding sources supported by the European Union and the Hungarian 
Government in the framework of the GINOP-2.3.2-15-2016-00040 project and the Tempus 
Public Foundation that awarded me with the Stipendium Hungaricum Scholarship in 2015. 
75 
 
During my long stay in Szeged, it became my second home and I developed precious 
relationships which I would definitely cherish throughout my life, for their unconditional 
love care and support for me, here I would like to thank László and Edit, Ilona Szőllősi 
Varga, Mousumidi and Subhenduda, my uncle Atanu and aunt Jayashree for always being 
there beside me in my both good and tough times. My friends like Tanmoy, Dhirend, 
Rakesh, Phani, Rishika, Paula, Mariam, Bettina, Sudiptada, Dileep and Kabi who always 
stood by me through thick and thin during my stay in Szeged.  
Finally, I would like to dedicate and thank the Almighty for showering me with His 
blessings, that helped me to endure the hard challenges and circumstances. I sincerely 
acknowledge my parents who always believed on my abilities and supported me 
throughout my career, yet last but not the least my husband Miltu with whom there is no 




Acharya G, Sonesson SE, Flo K, Räsänen J, Odibo A. Hemodynamic aspects of normal 
human fetoplacental (umbilical) circulation. Acta Obstetricia et Gynecologica 
Scandinavica 2016; 95(6):672-82. 
Agarwal A, Aponte-Mellado A, Premkumar BJ, Shaman A, Gupta S. The effects of 
oxidative stress on female reproduction: A review. Reproductive Biology and 
Endocrinology [Internet] 2012; 10:49.  
Al-Gubory KH, Fowler PA, Garrel C. The roles of cellular reactive oxygen species, 
oxidative stress, and antioxidants in pregnancy outcomes. International Journal of 
Biochemistry and Cell Biology 2010; 42(10):1634-50. 
Alderton WK, Cooper CE, Knowles RG. Nitric oxide synthases: Structure, function, and 
inhibition. Biochemical Journal [Internet] 2001; 357:593–615.  
American College of Obstetricians and Gynaecologists. Multifoetal gestations: twin, 
triplet, and higher-order multifoetal pregnancies. Practice Bulletin 169 2016; 128(4): e131-
46. 
Argyraki M, Damdimopoulou P, Chatzimeletiou K, Grimbizis GF, Tarlatzis BC, Syrrou 
M, Lambropoulos A. In-utero stress and mode of conception: Impact on the regulation of 
imprinted genes, foetal development, and future health. Human Reproduction Update 
2019; 25(6):777-801. 
Ávila JGO, Echeverri I, Plata CA de, Castillo A. Impact of oxidative stress during 
pregnancy on foetal epigenetic patterns and early origin of vascular diseases. Nutrition 
Reviews 2015; 73(1):12-21. 
Bak A, Roszkowski K. Oxidative stress in pregnant women. Archives of Perinatal 
Medicine 2013; 19(3), 150-155. 
Balogh G, Chakraborty P, Dugmonits KN, Péter M, Végh AG, Vígh L, Hermesz E. 
Sustained maternal smoking-associated changes in the physico-chemical properties of 
foetal RBC membranes might serve as early markers for vascular comorbidities. 
Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids 2020; 
1865(4):158615. 
Barker DJP, Godfrey KM, Gluckman PD, Harding JE, Owens JA, Robinson JS. Foetal 
nutrition and cardiovascular disease in adult life. The Lancet 1993; 341(8850):938-41. 
Barthelmes J, Nägele MP, Ludovici V, Ruschitzka F, Sudano I, Flammer AJ. Endothelial 
dysfunction in cardiovascular disease and Flammer syndrome-similarities and differences. 
EPMA Journal 2017; 8(2):99-109. 
77 
 
Benedetti A, Comporti M, Esterbauer H. Identification of 4-hydroxynonenal as a cytotoxic 
product originating from the peroxidation of liver microsomal lipids. Biochimica et 
Biophysica Acta - Lipids and Lipid Metabolism [Internet] 1980; 620:281–296. 
Benirschke K, Burton GJ, Baergen RN. Book chapter - Anatomy and Pathology of the 
Umbilical Cord. Pathology of the Human Placenta 5th edition 2012. 
Berk BC, Haendeler J, Sottile J. Angiotensin II, atherosclerosis, and aortic aneurysms. 
Journal of Clinical Investigation 2000; 105(11):1525-6. 
Blanchette H. The rising cesarean delivery rate in America: What are the consequences? 
Obstetrics and Gynecology 2011; 118(3):687-690. 
Blondel B, Kaminski M. Trends in the occurrence, determinants, and consequences of 
multiple births. Seminars in Perinatology 2002; 26(4):239-49. 
Bortolus R, Parazzini F, Chatenoud L, Benzi G, Bianchi MM, Marini A. The epidemiology 
of multiple births. Human Reproduction Update 1999; 5(2):179-87. 
Bosman GJCGM. Disturbed red blood cell structure and function: An exploration of the 
role of red blood cells in neurodegeneration. Frontiers in Medicine 2018; 5:1–6. 
Breathnach FM, McAuliffe FM, Geary M, Daly S, Higgins JR, Dornan J, Morrison JJ, 
Burke G, Higgins S, Dicker P, et al. Definition of intertwin birth weight discordance. 
Obstetrics and Gynecology 2011; 118(1):94-103. 
Buhling KJ, Henrich W, Starr E, Lubke M, Bertram S, Siebert G, Dudenhausen JW. Risk 
for gestational diabetes and hypertension for women with twin pregnancy compared to a 
singleton pregnancy. Archives of Gynecology and Obstetrics 2003; 269(1):33-6. 
Buonocore G, Perrone S. Biomarkers of oxidative stress in the foetus and new-born. 
Hematology Meeting Reports (formerly Haematologica Reports) 2009; 2(10). 
Burton GJ, Jauniaux E. Oxidative stress. Best Practice and Research: Clinical Obstetrics 
and Gynaecology [Internet] 2011; 25:287–299.  
Bydlowski SP, Debes AA, Maselli LMF, Janz FL. Características biológicas das células-
tronco mesenquimais. Revista Brasileira de Hematologia e Hemoterapia 2009; 31, 25-35. 
Capettini LSA, Cortes SF, Silva JF, Alvarez-Leite JI, Lemos VS. Decreased production of 
neuronal NOS-derived hydrogen peroxide contributes to endothelial dysfunction in 
atherosclerosis. British Journal of Pharmacology [Internet] 2011; 164:1738–1748.  
Carpenter AE, Jones TR, Lamprecht MR, Clarke C, Kang IH, Friman O, Guertin DA, 
Chang JH, Lindquist RA, Moffat J, et al. CellProfiler: Image analysis software for 
identifying and quantifying cell phenotypes. Genome Biology 2006; 7(10): R100. 
Casas AI, Dao VTV, Daiber A, Maghzal GJ, Lisa F Di, Kaludercic N, Leach S, Cuadrado 
A, Jaquet V, Seredenina T, et al. Reactive Oxygen-Related Diseases: Therapeutic Targets 




Cau SBA, Carneiro FS, Tostes RC. Differential modulation of nitric oxide synthases in 
aging: Therapeutic opportunities. Frontiers in Physiology [Internet] 2012; 3:218. 
Chakraborty P, Dugmonits KN, Orvos H, Hermesz E. Mature twin neonates exhibit 
oxidative stress via nitric oxide synthase dysfunctionality: A prognostic stress marker in 
the red blood cells and umbilical cord vessels. Antioxidants 2020; 9(9), 845. 
Chakraborty P, Dugmonits KN, Végh AG, Hollandi R, Horváth P, Maléth J, Hegyi P, 
Németh G, Hermesz E. Failure in the compensatory mechanism in red blood cells due to 
sustained smoking during pregnancy. Chemico-Biological Interactions 2019; 313:108821. 
Choi SH, Park YS, Shim KS, Choi YS, Chang JY, Hahn WH, Bae CW. Recent trends in 
the incidence of multiple births and its consequences on perinatal problems in Korea. 
Journal of Korean Medical Science 2010; 25(8):1191-6. 
Chung FL, Nath RG, Ocando J, Nishikawa A, Zhang L. Deoxyguanosine adducts of t-4-
Hydroxy-2-nonenal are endogenous DNA lesions in rodents and humans: Detection and 
potential sources. Cancer Research [Internet] 2000; 60(6):1507-11. 
Cleary-Goldman J, D’Alton ME. Growth Abnormalities and Multiple Gestations. 
Seminars in Perinatology 2008; 32(3):206-12. 
Collins J. Global epidemiology of multiple births. Reproductive biomedicine online 2007; 
15 Suppl 3:45-52. 
Colton CA, Vitek MP, Wink DA, Xu Q, Cantillana V, Previti ML, Nostrand WE Van, 
Weinberg B, Dawson H. No synthase 2 (NOS2) deletion promotes multiple pathologies in 
a mouse model of Alzheimer’s disease. Proceedings of the National Academy of Sciences 
of the United States of America 2006; 103(41):15273. 
Cortese-krott MM, Kelm M. Redox Biology Endothelial nitric oxide synthase in red blood 
cells: Key to a new erythrocrine function? Redox Biology [Internet] 2014; 2:251–258.  
Cortese-Krott MM, Rodriguez-Mateos A, Sansone R, Kuhnle GGC, Thasian-Sivarajah S, 
Krenz T, Horn P, Krisp C, Wolters D, Heiß C, et al. Human red blood cells at work: 
Identification and visualization of erythrocytic eNOS activity in health and disease. Blood 
2012; 120(20):4229-37. 
Courtney JA, Cnota JF, Jones HN. The role of abnormal placentation in congenital heart 
disease; Cause, correlate, or consequence? Frontiers in Physiology 2018; 9:1045. 
Davis JM, Auten RL. Maturation of the antioxidant system and the effects on preterm birth. 
Seminars in Foetal and Neonatal Medicine 2010; 15(4):191-5. 
Diederich L, Suvorava T, Sansone R, Keller TCS, Barbarino F, Sutton TR, Kramer CM, 
Lückstädt W, Isakson BE, Gohlke H, et al. On the effects of reactive oxygen species and 
nitric oxide on red blood cell deformability. Frontiers in Physiology 2018; 9:332. 
79 
 
Dimmeler S, Fleming I, Fisslthaler B, Hermann C, Busse R, Zeiher AM. Activation of 
nitric oxide synthase in endothelial cells by Akt- dependent phosphorylation. Nature 1999; 
399(6736):601-5. 
Ding H, Triggle CR. Endothelial cell dysfunction and the vascular complications 
associated with type 2 diabetes: assessing the health of the endothelium. Vascular health 
and risk management 2005; 1(1):55–71. 
Doorn JA, Petersen DR. Covalent adduction of nucleophilic amino acids by 4-
hydroxynonenal and 4-oxononenal. Chemico-Biological Interactions 2003; 143-144:93-
100. 
Dugmonits KN, Chakraborty P, Hollandi R, Zahorán S, Pankotai-Bodó G, Horváth P, 
Orvos H, Hermesz E. Maternal Smoking Highly Affects the Function, Membrane Integrity, 
and Rheological Properties in Foetal Red Blood Cells. Oxidative Medicine and Cellular 
Longevity 2019; 2019: 1509798. 
Dugmonits KN, Ferencz A, Zahoran S, Lazar R, Talapka P, Orvos H, Hermesz E. Elevated 
levels of macromolecular damage are correlated with increased nitric oxide synthase 
expression in erythrocytes isolated from twin neonates. British journal of haematology 
2016; 174:932–941.  
Durante W, Johnson FK, Johnson RA. Arginase: A critical regulator of nitric oxide 
synthesis and vascular function. Clinical and Experimental Pharmacology and Physiology 
[Internet] 2007; 34:906–911.  
Elms S, Chen F, Wang Y, Qian J, Askari B, Yu Y, Pandey D, Iddings J, Caldwell RB, 
Fulton DJ. Insights into the arginine paradox: evidence against the importance of the 
subcellular location of arginase and eNOS. American journal of physiology Heart and 
circulatory physiology [Internet] 2013; 305(5): H651-66. 
Espinosa-Diez C, Miguel V, Mennerich D, Kietzmann T, Sánchez-Pérez P, Cadenas S, 
Lamas S. Antioxidant responses and cellular adjustments to oxidative stress. Redox 
Biology 2015; 6:183–197.  
Esterbauer H, Schaur RJ, Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, 
malonaldehyde and related aldehydes. Free Radical Biology and Medicine [Internet] 1991; 
11(1):81-128. 
Fahmy M. Umbilicus and Umbilical Cord 2018; Book chapter 1st edition: 
DOI:10.1007/978-3-319-62383-2. 
Fan F, Sun L, Zhang D, Zhu L, Wang S, Wang D. Original Article Effects of red blood 
cell supernatants on hypoxia/reoxygenation injury in H9C2 cells. Int J Clin Exp Med 
[Internet] 2018; 11(4):3612-3619. 
Feron O, Saldana F, Michel JB, Michel T. The endothelial nitric-oxide synthase-caveolin 
regulatory cycle. Journal of Biological Chemistry [Internet] 1998; 273(6):3125-8. 
80 
 
Foley MR. Maternal adaptations to pregnancy: Cardiovascular and hemodynamic changes. 
UpToDate 2018. 
Ford J. Red blood cell morphology. International Journal of Laboratory Hematology 2013; 
35(3):351-357. 
Förstermann U. Janus-faced role of endothelial NO synthase in vascular disease: 
Uncoupling of oxygen reduction from NO synthesis and its pharmacological reversal. 
Biological Chemistry [Internet] 2006; 387(12):1521-33. 
Förstermann U, Münzel T. Endothelial nitric oxide synthase in vascular disease: From 
marvel to menace. Circulation [Internet] 2006; 113(13):1708-14.  
Fulton D, Gratton JP, McCabe TJ, Fontana J, Fujio Y, Walsh K, Franke TF, 
Papapetropoulos A, Sessa WC. Regulation of endothelium-derived nitric oxide production 
by the protein kinase Akt. Nature 1999; 399(6736):597-601. 
Gallagher PG. Red cell membrane disorders. Hematology Am Soc Hematol Educ Program. 
2005; 13-8.  
Geng YJ, Wu Q, Muszynski M, Hansson GK, Libby P. Apoptosis of vascular smooth 
muscle cells induced by in vitro stimulation with interferon-γ, tumor necrosis factor-α, and 
interleukin-1β. Arteriosclerosis, Thrombosis, and Vascular Biology 1996; 16(1):19-27. 
Georgeson GD, Szony BJ, Streitman K, Varga IS, Kovács A, Kovács L, László A. 
Antioxidant enzyme activities are decreased in preterm infants and neonates born via 
caesarean section. European Journal of Obstetrics and Gynecology and Reproductive 
Biology 2002; 103(2):136-139. 
Giles W, O’Callaghan S, Read M, Gude N, King R, Brennecke S. Placental nitric oxide 
synthase activity and abnormal umbilical artery flow velocity waveforms. Obstetrics and 
Gynecology 1997; 89(1):49-52. 
Gilliland SE, Speck ML. Biological Response of Lactic Streptococci and Lactobacilli to 
Catalase1. Applied Microbiology [Internet] 1969; 17(6):797-800. 
Godfrey KM, Barker DJ. Foetal programming and adult health. Public Health Nutrition 
2001; 4(2B):611-24. 
Gongora MC, Qin Z, Laude K, Kim HW, McCann L, Folz JR, Dikalov S, Fukai T, Harrison 
DG. Role of extracellular superoxide dismutase in hypertension. Hypertension 2006; 
48(3):473-81. 
Granger JP, Alexander BT, Llinas MT, Bennett WA, Khalil RA. Pathophysiology of 
hypertension during preeclampsia linking placental ischemia with endothelial dysfunction. 
Hypertension 2001; 38(3 Pt 2):718-22. 
Gremeau AS, Brugnon F, Bouraoui Z, Pekrishvili R, Janny L, Pouly JL. Outcome and 
feasibility of elective single embryo transfer (eSET) policy for the first and second 
81 
 
IVF/ICSI attempts. European Journal of Obstetrics and Gynecology and Reproductive 
Biology [Internet] 2012; 160(1):45-50.  
Haas S de, Ghossein-Doha C, Kuijk SMJ van, Drongelen J van, Spaanderman MEA. 
Physiological adaptation of maternal plasma volume during pregnancy: a systematic 
review and meta-analysis. Ultrasound in Obstetrics & Gynecology 2017; 49(2):177-187. 
Hackshaw A, Rodeck C, Boniface S. Maternal smoking in pregnancy and birth defects: A 
systematic review based on 173 687 malformed cases and 11.7 million controls. Human 
Reproduction Update 2011; 17(5):589-604. 
Halliwell B. Reactive oxygen species in living systems: Source, biochemistry, and role in 
human disease. The American Journal of Medicine 1991; 91(3C):14S-22S. 
Hayes E. Review of “Multiple Pregnancy: Epidemiology, Gestation & Perinatal Outcome. 
Second Edition.” Journal of Experimental & Clinical Assisted Reproduction 2005; 2:12. 
Heitzer T, Schlinzig T, Krohn K, Meinertz T, Münzel T. Endothelial dysfunction, 
oxidative stress, and risk of cardiovascular events in patients with coronary artery disease. 
Circulation [Internet] 2001; 104(22):2673-8. 
Hileman EA, Achanta G, Huang P. Superoxide dismutase: An emerging target for cancer 
therapeutics. Expert Opinion on Therapeutic Targets 2001; 5(6):697-710. 
Hollier LM, McIntire DD, Leveno KJ. The outcome of twin pregnancies according to intra-
pair birth weight differences. Obstetrics and Gynecology 1999; 94(6):1006-10. 
Horvath P, Wild T, Kutay U, Csucs G. Machine Learning Improves the Precision and 
Robustness of High-Content Screens. Journal of Biomolecular Screening 2011; 
16(9):1059-67. 
Huie RE, Padmaja S. The reaction of no with superoxide. Free Radical Research 1993; 
18(4):195-9. 
Hutter D, Kingdom J, Jaeggi E. Causes and Mechanisms of Intrauterine Hypoxia and Its 
Impact on the Foetal Cardiovascular System: A Review. International Journal of Pediatrics 
2010; 2010:401323. 
Jacobsson B, Ladfors L, Milsom I. Advanced maternal age and adverse perinatal outcome. 
Obstetrics and Gynecology 2004; 104(4):727-33. 
Ježek P, Hlavatá L. Mitochondria in the homeostasis of reactive oxygen species in cell, 
tissues, and organism. International Journal of Biochemistry and Cell Biology [Internet] 
2005; 37(12):2478-503. 
Jones CA, Christensen AL, Salihu H, Carpenter W, Petrozzino J, Abrams E, Sills ES, Keith 
LG. Prediction of individual probabilities of livebirth and multiple birth events following 
in vitro fertilization (IVF): a new outcomes counselling tool for IVF providers and patients 
using HFEA metrics. Journal of experimental & clinical assisted reproduction [Internet] 
2011; 8:3.  
82 
 
Kalyanaraman B. Teaching the basics of redox biology to medical and graduate students: 
Oxidants, antioxidants, and disease mechanisms. Redox Biology [Internet] 2013; 1(1):244-
57. 
Karbowski B, Bauch HJ, Schneider HPG. Functional differentiation of the vascular 
endothelium in high-risk pregnancies. Zeitschrift fur Geburtshilfe und Perinatologie 1989; 
193(1):8-12. 
Kehrer JP. The Haber-Weiss reaction and mechanisms of toxicity. Toxicology 2000; 
149(1):43-50. 
Kingdom JCP, Kaufmann P. Oxygen and placental villous development: origins of foetal 
hypoxia. Placenta 1997; 18(8):613-21. 
Kingdom JCP, Kaufmann P. Oxygen and placental vascular development. Advances in 
Experimental Medicine and Biology 1999; 474:259-75. 
Kirkinezos IG, Moraes CT. Reactive oxygen species and mitochondrial diseases. Seminars 
in Cell and Developmental Biology 2001; 12(6):449-57. 
Kleinbongard P, Schulz R, Rassaf T, Lauer T, Dejam A, Jax T, Kumara I, Gharini P, 
Kabanova S, Özüyaman B, et al. Red blood cells express a functional endothelial nitric 
oxide synthase. Blood 2006; 107(7):2943-51. 
Kleinert H, Art J, Pautz A. Regulation of the Expression of Inducible Nitric Oxide 
Synthase. Nitric Oxide 2010; 23(2):75-93. 
Koppenol WH, Moreno JJ, Pryor WA, Ischiropoulos H, Beckman JS. Peroxynitrite, a 
Cloaked Oxidant Formed by Nitric Oxide and Superoxide. Chemical Research in 
Toxicology 1992; 5(6):834-42. 
Krause BJ, Hanson MA, Casanello P. Role of nitric oxide in placental vascular 
development and function. Placenta [Internet] 2011; 32(11): 797–805. 
Krotz S, Fajardo J, Ghandi S, Patel A, Keith LG. Hypertensive Disease in Twin 
Pregnancies: A Review. Twin Research 2002; 5(1):8-14. 
Krüger-Genge A, Blocki A, Franke RP, Jung F. Vascular endothelial cell biology: An 
update. International Journal of Molecular Sciences [Internet] 2019; 20(18):4411. 
Kuhn V, Diederich L, Keller TCS, Kramer CM, Lückstädt W, Panknin C, Suvorava T, 
Isakson BE, Kelm M, Cortese-Krott MM. Red Blood Cell Function and Dysfunction: 
Redox Regulation, Nitric Oxide Metabolism, Anaemia. Antioxidants & Redox Signaling 
2017; 26(13):718-742. 
Kültz D. Molecular and evolutionary basis of the cellular stress response. Annual Review 
of Physiology [Internet] 2005; 67:225–257.  
Li H, Förstermann U. Uncoupling of endothelial NO synthase in atherosclerosis and 
vascular disease. Current Opinion in Pharmacology [Internet] 2013; 13(2):161-7. 
83 
 
Li H, Horke S, Förstermann U. Oxidative stress in vascular disease and its pharmacological 
prevention. Trends in Pharmacological Sciences [Internet] 2013; 34(6):313-9. 
Linderkamp O, Ozanne P, Wu PYK, Meiselman HJ. Red blood cell aggregation in preterm 
and term neonates and adults. Pediatric Research 1984; 18(12):1356-60. 
Liu J, García-Cardeña G, Sessa WC. Palmitoylation of endothelial nitric oxide synthase is 
necessary for the optimal stimulated release of nitric oxide: Implications for caveolae 
localization. Biochemistry [Internet] 1996; 35(41):13277-81. 
Liu XM, Chapman GB, Peyton KJ, Schafer AI, Durante W. Carbon monoxide inhibits 
apoptosis in vascular smooth muscle cells. Cardiovascular Research 2002; 55(2):396-405. 
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin 
phenol reagent. The Journal of biological chemistry 1951; 193(1):265-75. 
Lucas R, Fulton D, Caldwell RW, Romero MJ. Arginase in the vascular endothelium: 
Friend or foe? Frontiers in Immunology 2014; 5: 589. 
Machin G. Non-identical monozygotic twins, intermediate twin types, zygosity testing, 
and the non-random nature of monozygotic twinning: A review. American Journal of 
Medical Genetics, Part C: Seminars in Medical Genetics 2009; 151C (2):110-27. 
Manuel Barrios Arpi L. Histology of Umbilical Cord in Mammals. 2019; Open access 
peer-reviewed chapter: DOI:10.5772/intechopen.80766. 
Marla SS, Lee J, Groves JT. Peroxynitrite rapidly permeates phospholipid membranes. 
Proceedings of the National Academy of Sciences of the United States of America 1997; 
94(26):14243-8. 
Martin JA, Hamilton BE, Osterman MJK. Three decades of twin births in the United States, 
1980-2009. NCHS data brief 2012; (80):1-8. 
Masilamani V, Alzahrani K, Devanesan S, Alqahtani H, AlSalhi MS. Smoking induced 
haemolysis: Spectral and microscopic investigations. Scientific Reports 2016; 6:21095. 
Mattson MP. Hormesis and disease resistance: Activation of cellular stress response 
pathways. Human and Experimental Toxicology [Internet] 2008; 27(2):155-62.  
Mauro A, Buscemi M, Provenzano S, Gerbino A. Human umbilical cord expresses several 
vasoactive peptides involved in the local regulation of vascular tone: Protein and gene 
expression of Orphanin, Oxytocin, ANP, eNOS, and iNOS. Folia Histochemica et 
Cytobiologica 2011; 49(2):211-8. 
Mccord JM, Fridovich I. Superoxide dismutases: You’ve come a long way, baby. 
Antioxidants and Redox Signaling 2014; 20(10):1548-9. 
Meekins JW, Luckas MJM, Pijnenborg R, McFadyen IR. Histological study of decidual 
spiral arteries and the presence of maternal erythrocytes in the intervillous space during 
the first trimester of normal human pregnancy. Placenta 1997; 18(5–6):459-464. 
84 
 
Messner B, Bernhard D. Smoking and Cardiovascular Disease. Arterioscler Thromb Vasc 
Biol 2014; 34(3):509-15. 
Michel T, Feron O. Nitric oxide synthases: Which, where, how, and why? Journal of 
Clinical Investigation [Internet] 1997; 100(9):2146–2152.  
Miller J, Chauhan SP, Abuhamad AZ. Discordant twins: Diagnosis, evaluation, and 
management. American Journal of Obstetrics and Gynecology 2012; 206(1):10-20. 
Minami T, Muramatsu M, Kume T. Organ/tissue-specific vascular endothelial cell 
heterogeneity in health and disease. Biological and Pharmaceutical Bulletin [Internet] 
2019; 42(10):1609-1619.  
Minetti M, Agati L, Malorni W. The microenvironment can shift erythrocytes from a 
friendly to a harmful behavior: Pathogenetic implications for vascular diseases. 
Cardiovascular Research [Internet] 2007; 75(1):21-8. 
Mizrahi O, Ish Shalom E, Baniyash M, Klieger Y. Quantitative Flow Cytometry: Concerns 
and Recommendations in Clinic and Research. Cytometry Part B - Clinical Cytometry 
2018; 94(2):211-218. 
Mohandas N, Gallagher PG. Red cell membrane: past, present, and future. Blood 2009; 
112(10):3939-48. 
Montorfano I, Becerra A, Cerro R, Echeverría C, Sáez E, Morales MG, Fernández R, 
Cabello-Verrugio C, Simon F. Oxidative stress mediates the conversion of endothelial cells 
into myofibroblasts via a TGF-b1 and TGF-b2-dependent pathway. Laboratory 
Investigation [Internet] 2014; 94(10):1068-82. 
Nair J, Flora S De, Izzotti A, Bartsch H. Lipid peroxidation-derived etheno-DNA adducts 
in human atherosclerotic lesions. Mutation Research - Fundamental and Molecular 
Mechanisms of Mutagenesis [Internet] 2007; 621(1-2):95-105. 
Naro E Di, Ghezzi F, Raio L, Franchi M, D’Addario V. Umbilical cord morphology and 
pregnancy outcome. European Journal of Obstetrics and Gynecology and Reproductive 
Biology 2001; 96(2):150-7. 
Nedeljkovic ZS, Gokce N, Loscalzo J. Mechanisms of oxidative stress and vascular 
dysfunction. Postgraduate Medical Journal [Internet] 2003; 79(930):195–200.  
Nishikawa E, Matsumoto T, Isige M, Tsuji T, Mugisima H, Takahashi S. Comparison of 
capacities to maintain hematopoietic stem cells among different types of stem cells derived 
from the placenta and umbilical cord. Regenerative Therapy 2016; 4:48–61. 
Njaa BL.Book-Kirkbride’s Diagnosis of Abortion and Neonatal Loss in Animals, 4th 
Edition.2011. 
Nordberg J, Arnér ESJ. Reactive oxygen species, antioxidants, and the mammalian 
thioredoxin system. Free Radical Biology and Medicine [Internet] 2001; 31(11):1287-312.  
85 
 
Norwitz ER, Edusa V, Park JS. Maternal physiology and complications of multiple 
pregnancies. Seminars in Perinatology 2005; 29(5):338-48. 
Obiechina NJ, Okolie VE, Eleje GU, Okechukwu ZC, Anemeje OA. Twin versus singleton 
pregnancies: the incidence, pregnancy complications, and obstetric outcomes in a Nigerian 
tertiary hospital. International Journal of Women’s Health 2011; 3:227-30. 
Özüyaman B, Grau M, Kelm M, Merx MW, Kleinbongard P. RBC NOS: regulatory 
mechanisms and therapeutic aspects. Trends in Molecular Medicine 2008; 14(7):314-22. 
Packer MA, Porteous CM, Murphy MP. Superoxide production by mitochondria in the 
presence of nitric oxide forms peroxynitrite. Biochemistry and Molecular Biology 
International 1996; 40(3):527-34. 
Pautz A, Art J, Hahn S, Nowag S, Voss C, Kleinert H. Regulation of the expression of 
inducible nitric oxide synthase. Nitric Oxide - Biology and Chemistry [Internet] 2010; 
23(2):75-93. 
Pernow J, Jung C. Arginase as a potential target in the treatment of cardiovascular disease: 
Reversal of arginine steal? Cardiovascular Research [Internet] 2013; 98(3):334-43. 
Pernow J, Mahdi A, Yang J, Zhou Z. Red blood cell dysfunction: A new player in 
cardiovascular disease. Cardiovascular Research 2019; 115(11):1596-1605. 
Perrone S, Laschi E, Buonocore G. Biomarkers of oxidative stress in the foetus and the 
new-born. Free Radical Biology and Medicine 2019; 142:23-31. 
Perrone S, Negro S, Tataranno ML, Buonocore G. Oxidative stress and antioxidant 
strategies in newborns. Journal of Maternal-Foetal and Neonatal Medicine 2010; 23 Suppl 
3:63-5. 
Perrone S, Tataranno ML, Stazzoni G, Buonocore G. Biomarkers of oxidative stress in 
foetal and neonatal diseases. Journal of Maternal-Foetal and Neonatal Medicine 2012; 
25(12):2575-8. 
Phaniendra A, Jestadi DB, Periyasamy L. Free Radicals: Properties, Sources, Targets, and 
Their Implication in Various Diseases. Indian Journal of Clinical Biochemistry 2015; 
30(1):11-26. 
Pharoah POD, Glinianaia S V., Rankin J. Congenital anomalies in multiple births after the 
early loss of a conceptus. Human Reproduction 2009; 24(3):726–731. 
Pison G, D’Addato A V. Frequency of twin births in developed countries. Twin Research 
and Human Genetics 2006; 9(2):250-9. 
Pretorius E, Plooy JN Du, Soma P, Keyser I, Buys A V. Smoking and fluidity of 
erythrocyte membranes: A high-resolution scanning electron and atomic force microscopy 
investigation. Nitric Oxide - Biology and Chemistry 2013; 35:42-6. 
Prieto CP, Krause BJ, Quezada C, Martin RS, Sobrevia L, Casanello P. Hypoxia-reduced 
nitric oxide synthase activity is partially explained by higher arginase-2 activity and 
86 
 
cellular redistribution in human umbilical vein endothelium. Placenta [Internet] 2011; 
32(12):932-40. 
Ratovitski EA, Bao C, Quick RA, McMillan A, Kozlovsky C, Lowenstein CJ. An inducible 
nitric-oxide synthase (NOS)-associated protein inhibits NOS dimerization and activity. 
Journal of Biological Chemistry 1999; 274(42):30250-7. 
Rodríguez-Rodríguez P, Ramiro-Cortijo D, Reyes-Hernández CG, López de Pablo AL, 
Carmen González M, Arribas SM. Implication of oxidative stress in foetal programming 
of cardiovascular disease. Frontiers in Physiology 2018; 9: 602. 
Schächinger V, Britten MB, Zeiher AM. Prognostic impact of coronary vasodilator 
dysfunction on adverse long-term outcome of coronary heart disease. Circulation [Internet] 
2000; 101(16):1899-906. 
Schödel J, Padmapriya P, Marx A, Huang PL, Ertl G, Kuhlencordt PJ. Expression of 
neuronal nitric oxide synthase splice variants in atherosclerotic plaques of apoE knockout 
mice. Atherosclerosis [Internet] 2009; 206(2):383–389. 
Schwarz PM, Kleinert H, Förstermann U. Potential Functional Significance of Brain-Type 
and Muscle-Type Nitric Oxide Synthase I Expressed in Adventitia and Media of Rat Aorta. 
Arteriosclerosis, Thrombosis, and Vascular Biology [Internet] 1999; 19(11):2584-90. 
Selye H. Stress and disease. Science [Internet] 1955; 122(3171):625-31. 
Sharma AK, Taneja G, Khanna D, Rajput SK. Reactive oxygen species: Friend or foe? 
RSC Advances 2015; 5:57267–57276. 
Shu X, Keller TCS, Begandt D, Butcher JT, Biwer L, Keller AS, Columbus L, Isakson BE. 
Endothelial nitric oxide synthase in the microcirculation. Cellular and Molecular Life 
Sciences 2015; 72(23):4561-4575. 
Sibai BM, Hauth J, Caritis S, Lindheimer MD, MacPherson C, Klebanoff M, VanDorsten 
JP, Landon M, Miodovnik M, Paul R, et al. Hypertensive disorders in twin versus singleton 
gestations. American Journal of Obstetrics and Gynecology 2000; 182(4):938-42. 
Sies H. Oxidative stress: A concept in redox biology and medicine. Redox Biology 2015; 
4:180-3. 
Silva BR, Pernomian L, Bendhack LM. Contribution of oxidative stress to endothelial 
dysfunction in hypertension. Frontiers in Physiology 2012; 3:441. 
Singla PN, Tyagi M, Kumar A, Dash D, Shankar R. Foetal growth in maternal anaemia. 
Journal of Tropical Pediatrics 1997; 43(2):89-92. 
Siu SC, Colman JM, Sorensen S, Smallhorn JF, Farine D, Amankwah KS, Spears JC, 
Sermer M. Adverse neonatal and cardiac outcomes are more common in pregnant women 
with cardiac disease. Circulation 2002; 105(18):2179-84. 
87 
 
Smith K, Li Y, Piccinini F, Csucs G, Balazs C, Bevilacqua A, Horvath P. CIDRE: An 
illumination-correction method for optical microscopy. Nature Methods 2015; 12(5):404-
6. 
Soma P, Pretorius E. Interplay between ultrastructural findings and atherothrombotic 
complications in type 2 diabetes mellitus. Cardiovascular Diabetology 2015; 14:96. 
Spurway J, Logan P, Pak S. The development, structure, and blood flow within the 
umbilical cord with particular reference to the venous system. Australasian Journal of 
Ultrasound in Medicine 2012; 15(3): 97–102. 
Stanek J. Hypoxic patterns of placental injury: A review. Archives of Pathology and 
Laboratory Medicine 2013; 137(5):706-20. 
Stock S, Norman J. Preterm and term labor in multiple pregnancies. Seminars in Foetal 
and Neonatal Medicine 2010; 15(6):336-41. 
Su R-N, Zhu W-W, Wei Y-M, Wang C, Feng H, Lin L, Yang H-X. Maternal and neonatal 
outcomes in multiple pregnancies: A multicentre study in the Beijing population. Chronic 
Diseases and Translational Medicine 2015; 1(4):197-202. 
Tan BL, Norhaizan ME, Liew WPP, Rahman HS. Antioxidant and oxidative stress: A 
mutual interplay in age-related diseases. Frontiers in Pharmacology [Internet] 2018; 
9:1162. 
Thaete LG, Dewey ER, Neerhof MG. Endothelin and the regulation of uterine and 
placental perfusion in hypoxia-induced foetal growth restriction. Journal of the Society for 
Gynecologic Investigation 2004; 11(1):16-21. 
Tomasian D, Keaney JF, Vita JA. Antioxidants and the bioactivity of endothelium-derived 
nitric oxide. Cardiovascular Research [Internet] 2000; 47(3):426–435.  
Tsutsui M. Neuronal nitric oxide synthase as a novel anti-atherogenic factor. Journal of 
atherosclerosis and thrombosis [Internet] 2004; 11(2):41-8.  
Uchida K, Stadtman ER. Covalent attachment of 4-hydroxynonenal to glyceraldehyde-3-
phosphate dehydrogenase. Possible involvement of intra- and intermolecular cross-linking 
reaction. Journal of Biological Chemistry 1993; 268(9):6388-6393. 
Vanhoutte PM, Shimokawa H, Feletou M, Tang EHC. Endothelial dysfunction and 
vascular disease – a 30th anniversary update. Acta Physiologica [Internet] 2017; 
219(1):22-96.  
Villegas E, Gilliland SE. Hydrogen Peroxide Production by Lactobacillus delbrueckii 
Subsp. Lactis I at 5°C. Journal of Food Science 1998; 63(6):1070–1074. 
Vogel JP, Torloni MR, Seuc A, Betrán AP, Widmer M, Souza JP, Merialdi M. Maternal 
and Perinatal Outcomes of Twin Pregnancy in 23 Low- and Middle-Income Countries. 
PLoS ONE 2013; 8(8): e70549. 
Watson JD. Type 2 diabetes is a redox disease. The Lancet 2014; 383(9919):841-3. 
88 
 
Weber MA, Sebire NJ. Genetics and developmental pathology of twinning. Seminars in 
Foetal and Neonatal Medicine 2010; 15(6):313-318. 
Weissman A, Jakobi P, Bronshtein M, Goldstein I. Sonographic measurements of the 
umbilical cord and vessels during normal pregnancies. Journal of Ultrasound in Medicine 
1994; 13(1):11-4. 
Williams LA, Evans SF, Newnham JP. A prospective cohort study of factors influencing 
the relative weights of the placenta and the newborn infant. British Medical Journal 1997; 
314(7098):1864-8. 
Yang J, Gonon AT, Sjöquist PO, Lundberg JO, Pernow J. Arginase regulates red blood 
cell nitric oxide synthase and export of cardioprotective nitric oxide bioactivity. 
Proceedings of the National Academy of Sciences of the United States of America 
[Internet] 2013; 110(37):15049-54. 
Yang Z, Ming XF. Arginase: The emerging therapeutic target for vascular oxidative stress 
and inflammation. Frontiers in Immunology 2013; 4:149. 
Yoshida A, Watanabe K, Iwasaki A, Kimura C, Matsushita H, Wakatsuki A. Placental 
oxidative stress and maternal endothelial function in pregnant women with normotensive 
foetal growth restriction. Journal of Maternal-Foetal and Neonatal Medicine 2018; 
31(8):1051-1057. 
Young BC, Wylie BJ. Effects of Twin Gestation on Maternal Morbidity. Seminars in 
Perinatology 2012; 36(3):162-8. 
Young IS, Woodside J V. Antioxidants in health and disease. Journal of Clinical Pathology 
[Internet] 2001; 54(3):176-86. 
Yu X, Ge L, Niu L, Lian X, Ma H, Pang L. The dual role of inducible nitric oxide synthase 
in myocardial ischemia/reperfusion injury: Friend or foe? Oxidative Medicine and Cellular 
Longevity 2018; 2018:8364848. 
Zahorán S, Szántó PR, Bódi N, Bagyánszki M, Maléth J, Hegyi P, Sári T, Hermesz E. 
Sustained maternal smoking triggers endothelial-mediated oxidative stress in the umbilical 
cord vessels, resulting in vascular dysfunction. Antioxidants 2021; 10(4):583. 
Zhou C, Zou QY, Jiang YZ, Zheng J. Role of oxygen in fetoplacental endothelial 
responses: hypoxia, physiological normoxia, or hyperoxia? American journal of 
physiology Cell physiology 2020; 318(5): C943-C953. 
Zhou Z, Mahdi A, Tratsiakovich Y, Zahorán S, Kövamees O, Nordin F, Uribe Gonzalez 
AE, Alvarsson M, Östenson CG, Hermesz E, Andersson DC, et al. Erythrocytes from 
Patients with Type 2 Diabetes Induce Endothelial Dysfunction Via Arginase I. Journal of 




9. List of Publications 
Number of scientific publications: 6 
Total impact factor: 31.695 
MTMT identification number: 10053026 
 
1. Payal Chakraborty, Krisztina N. Dugmonits, Hajnalka Orvos, Edit Hermesz. Mature 
Twin Neonates Exhibit Oxidative Stress via Nitric Oxide Synthase Dysfunctionality: A 
Prognostic Stress Marker in the Red Blood Cells and Umbilical Cord Vessels. Antioxidants 
(2020); 9(9):845. doi: 10.3390/antiox9090845. IF: 6.312 
2. Payal Chakraborty, Ali Khamit, Edit Hermesz. Foetal oxygen supply can be improved 
by an effective cross-talk between foetal red blood cells and the vascular endothelial layer. 
Biochim Biophys Acta Mol Basis Dis (2021); 1867(11), 166243. doi: 
10.1016/j.bbadis.2021.166243. IF: 5.187 
3. Balogh Gábor*, Chakraborty Payal*, Dugmonits Krisztina*, Péter Mária*, Végh 
Attila G., Vígh László, Hermesz Edit. Sustained maternal smoking-associated changes in 
the Physico-chemical properties of foetal RBC membranes might serve as early markers 
for vascular comorbidities. Biochim Biophys Acta Mol Cell Biol Lipids 
(2020);1865(4):158615. doi: 10.1016/j.bbalip.2020.158615. IF: 4.698 
4. Chakraborty P*, Dugmonits KN*, Végh AG, Hollandi R, Horváth P, Maléth J, Hegyi 
P, Németh G, Hermesz E. Failure in the compensatory mechanism in red blood cells due 
to sustained smoking during pregnancy. Chem Biol Interact (2019); 313:108821. doi: 
10.1016/j.cbi.2019.108821. IF: 5.192 
5. Dugmonits KN, Chakraborty P, Hollandi R, Zahorán S, Pankotai-Bodó G, Horváth P, 
Orvos H, Hermesz E. Maternal Smoking Highly Affects the Function, Membrane Integrity, 
and Rheological Properties in Foetal Red Blood Cells. Oxid Med Cell Longev. (2019); 
1509798. doi: 10.1155/2019/1509798. IF: 6.543 
6. Nikolett Bódi, Diána Mezei, Payal Chakraborty, Zita Szalai, Bence Pál Barta, János 
Balázs, Zsolt Rázga, Edit Hermesz, Mária Bagyánszki. Correlation between the region-
specific thickening of ganglionic basement membrane and regionally decreased matrix 
metalloproteinase 9 expression in myenteric ganglia and its environment in type 1 diabetes. 
World Journal of Diabetes. (2021). 12(5): 658–672. doi: 10.4239/wjd. v12.i5.658. IF: 
3.763 





In the last 30 years, by modern in-vitro fertilization therapies, the proportion of twin/ 
multiple pregnancies have markedly increased and developed a new significant clinical 
database. There showed an elevation in the foetal, neonatal, and perinatal mortality rate of 
3-6 times in twins and 5-15 times in other multiple pregnancies in comparison to 
singletons. The state of pregnancy with enhanced metabolism and demand for oxygen 
definitely causes a significant burden on both the mother and the developing foetus, which 
further gets increased during twin pregnancy. In comparison to singletons, twin siblings’ 
experience an additional stress condition with the excessive oxygen demand, and sustains 
a long-lasting adverse intrauterine environment. Increased oxygen demand in the twin 
neonates develops an intrauterine hypoxic condition that can lead to loss of redox balance 
and follow with its harmful consequences such as delayed development commonly 
characterized by low birth weight, respiratory disorders, preterm birth, and morphological 
disorders.  
During pregnancy, the placenta and umbilical cord are the vital temporary organs to 
maintain the in-utero foetal development. The umbilical cord is entirely embryonic in 
origin, and the cord blood vessels are considered as a direct extension of the foetal 
circulation. The umbilical cord vein transports oxygen-rich blood and nutrients from the 
placenta to the foetus, and the two arteries carry the deoxygenated blood and waste 
products back to the placenta. The proper functioning of UC blood vessels is crucial in the 
fetoplacental circulation, to maintain the adequate supply of nutrients and oxygen to the 
developing foetus. 
The UC vascular system, including the endothelial cell layer together with the 
circulating red blood cell (RBC) population, are the primary targets that get affected due 
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to an increased oxidative stress condition. Thereby necessarily carrying the environmental-
induced morphological and functional changes indicate towards the effects experienced 
during the in-utero foetal development. Moreover, analysing the complications related to 
RBCs and the endothelial layer of the umbilical cord might serve as an important 
diagnostic tool for understanding the basic pathological processes leading to neonatal 
vascular diseases. In our study, we hypothesized that any kind of underlying molecular 
changes that determines the redox status of the cord vein might indicate the quality of the 
“nutrition” transferred from the mother to foetus, while the condition of the arteries 
provides more information concerning the “actual state” of the foetus.  
As the UC vessels lack innervations, it releases vasoactive entities like nitric oxide 
(NO) acting as the key in regulating the vascular tone and fetoplacental blood flow which 
gets derived by the endothelial nitric oxide synthase (NOS3) activity. The activation 
process of NOS3 is necessary to liberate the bioavailable NO, which depends on several 
factors. The active NOS3 dimeric conformational state is highly regulated by the L-
arginine substrate concentration, subcellular localization, presence of co-factors (e.g. 
tetrahydrobiopterin), diverse interacting proteins, and the post-translational modification 
by phosphorylation at Ser1177 residue via PI3-kinase/Akt kinase pathway.  
Impairment in the endothelial NO synthesis causes endothelial dysfunction. Recent 
studies draw attention to the possibility of an intimate communication between the vascular 
endothelium and the RBC population, which suggests RBCs can perform the vital sensory 
function in response to a wide range of vascular/endothelial dysfunctions/diseases. Most 
importantly current discoveries also presented that RBCs independently contain the 
functional NOS3 enzyme, which actively participates to synthesize, liberate, and export 
NO in the regulation of vascular tone. 
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In our work, we followed significant changes involved in the activation process of 
NOS3 that might affect the redox status and functionality of both the UC vessel’s 
endothelial layer and red blood cells - with a direct correlation on the birth weight and 
maturity level of the new-born twins. Our study selected the parameters that influence the 
dimerization step of the NOS3 enzyme, in presence of the enzyme Arginase1. Secondly, 
an alternative upregulation of inducible NOS (NOS2) enzyme might be a possible 
approach towards a compensatory/rescue mechanism. Hence we collected and examined 
the umbilical cord and red blood cell samples from both mature and preterm twins and 
neonates born from singleton pregnancies with different percentile values (25-95%). 
Our main findings can be summarized as follows: 
(1) During twin pregnancy, the activation of the NOS3 pathway in the umbilical cord 
vessels depends on the maturity level of the developing foetus - mature: > 37 weeks and 
preterm: 33-35 weeks’ birth –that follows a vascular-specific regulation: 
(a) Expression and phosphorylation of NOS3 at position Ser1177 in the umbilical vein 
endothelial cells of premature (33-35 weeks) twin siblings is comparable to age-
matched neonates, regardless of the neonatal birth weight. 
(b) Contrastingly, in matured twins (>37 weeks), NOS3 expression and its activation 
by phosphorylation at Ser1177 residue is significantly lower than the level measured 
to their age-matched singletons irrespective of their birth weight.  
(c) In the umbilical cord arteries, except the mature and premature normal-birthweight 
neonates, there are no significant changes detected in the NOS3 expression/activation 
when compared to their age-matched singletons. 
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(2) Except the mature twins with normal birthweight, in all the other examined populations 
showed, that the RBC-NOS3-NO pathway under hypoxic conditions may significantly 
contribute to the improvement of vascular tone and thus able to maintain the foetal blood 
flow due to an elevation in the NOS3 expression and/or activation. 
(3) Apart from the preterm neonates having a gestational age of 95th % percentile, most 
likely the levels of bioavailable NOS3-NO and RBC-NOS3-NO are unsatisfactory in all 
the other investigated groups, and thus an alternative NO-producing pathway NOS2 is 
highly induced to improve the foetal blood flow. 
(4) The expression level of Arginase1 in the RBCs of twin neonates is increased, which is 
partly due to the excessive presence of superoxide anions in the vascular system. 
(5) In the case of twin pregnancies, the level of pro-oxidant peroxynitrite anion in foetal 
RBCs is increased, which can also be associated with the higher availability of the 
superoxide anions. 
(6) Increased macromolecular damages were observed in connection to the elevated levels 
of the peroxynitrite anion, which was detected and determined by measuring the 
accumulation of 4-hydroxynonenal (4-HNE) level. Irrespective of maturity, arteries, and 
circulating RBCs were primarily affected. It is also shown that at the matured stages of 
twin pregnancy, the 4-HNE levels get significantly increased in the arteries. 
(7) Irrespective of the maturity level in the twin neonates, there occurs an increased 
frequency of morphological variants in the foetal RBCs. These phenotypic differences may 
be a useful indicator for any disturbances in the functional and/or physicochemical 




A modern in vitro megtermékenyítési terápiák alkalmazásának köszönhetően az 
utóbbi 30 évben megnőtt az iker/többes terhességek aránya, mely lehetőséget nyújtott új, 
klinikai szempontból jelentős adatbázis kiépítésére. Ikerterhesség esetén a 
magzati/újszülött kori halálozás 3-6 szorosa, míg többszörös terhesség esetén 5-15-szerese 
az egyszeres terhességek során tapasztalt értékeknek. A várandóság jelentős terhet jelent 
úgy az anya, mint a fejlődő magzat szervezetére. Az ikerterhesség fokozott oxigén igénye 
intrauterin hipoxiás állapot kialakulását eredményezi, mely a redox egyensúly 
elvesztéséhez vezethet, ennek összes következményével együtt, mint például fejlődései 
visszamaradottság, melyet leggyakrabban alacsony születési súly jellemez, légzési 
rendellenességek, koraszülöttség és morfológiai rendellenességek. 
A terhesség alatt a placenta és a köldökzsinór létfontosságú ideiglenes szervet 
képeznek a magzat fejlődésének fenntartása érdekében. A köldökzsinór teljes mértékben 
embrionális eredetű, a benne futó erek a magzati keringés közvetlen kiterjesztésének 
tekinthetőek. A köldökzsinór véna szállítja az oxigén dús vért és táplálékot a méhlepénytől 
a magzatig, a két artéria pedig a „fáradt” vért és a salakanyagot vissza a placentába. Az 
erek megfelelő működése meghatározó a fetoplacentális keringésben, a fejlődő magzat 
megfelelő tápanyag és oxigénellátásában. 
A köldökzsinór vaszkuláris rendszere, ezen belül is az endotél sejtréteg, együtt a 
keringő vörösvértes populációval a fokozott oxidatív stressz elsődleges elszenvedői, 
ezáltal szükségszerűen hordozzák a környezet indukálta morfológiai és funkcionális 
változásokat, melyek jelzés értékűek lehetnek a magzatra gyakorolt hatást illetően is. Ezért 
a vörösvértestek és a köldökzsinór endotél rétegével kapcsolatos komplikációk elemzése 
fontos eszköze lehet az újszülött kori érrendszeri betegségekhez vezető patológiás 
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folyamatok megértésének. Munkánk során feltételeztük, hogy a vénában bekövetkező 
változások jelzik az anya felől érkező, a magzati keringésbe jutó „káros anyagok” 
megjelenését, mintegy lenyomatai a magzatot ért káros hatásoknak. Az artériák állapota 
pedig a magzati válaszreakciókat tükrözi, így információt nyújtva az újszülöttek tényleges 
állapot tekintve.  
A köldökzsinór erek nem rendelkeznek beidegzéssel, ezért az endotél sejtek nitrogén 
monoxid szintáz (NOS3) aktivitása kulcsfontosságú az értónus és a fetoplacentális 
véráramlás szabályozásában. A NOS3 függő NO termelést több tényező befolyásolja. A 
NOS3 enzim dimer formában aktív. Ennek képződésben és a megfelelő elektron transzfer 
fenttartásában olyan tényezők játszanak szerepet, mint az L-arginin szubsztrát 
koncentrációja, az enzim szubcelluláris lokalizációja, ko-faktorok (pl. a 
tetrahidrobiopterin) és kölcsönható fehérjepartnerek jelenléte, posztranszlációs 
módosítások, mint például a Ser1177 oldallánc foszforilációja a PI3- / Akt-kináz útvonalon 
keresztül.  
Az endoteliális NO szintézis károsodása endoteliális diszfunkciót eredményezhet. A 
közelmúltban megjelent tanulmányok felhívják a figyelmet egy intim kommunikáció 
lehetőségére az ér-endotél és a vörösvértest populáció között, mely alapján feltételezhető 
hogy a vörösvértestek létfontosságú szenzor funkciót látnak el a vaszkuláris / endoteliális 
diszfunkciók / betegségek széles skálájára reagálva. Ugyancsak a közelmúlt jelentős 
felfedezései közt kell megemlítenünk, hogy a vörösvértestek önálló, funkcionális NOS3 
enzimmel rendelkeznek mely lehetővé teszi számukra, hogy nem csupán az endotél 
eredetű NO „sülyesztőjeként” működjenek, hanem maguk is aktív szereplőivé váljanak az 
értónus szabályozásának, a NO szintetizáló és exportáló funkciójuk révén.  
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Munkánk során a NOS3 aktivációs folyamatának változásaira fókuszáltunk, amelyek 
befolyásolhatják mind a köldökzsinór erek endoteliális rétegének, mind az vörös 
vértesteknek a redox állapotát, funkcionalitását - jelentős hatást gyakorolva az újszülött 
ikrek születési súlyára és érettségi szintjére. Vizsgálataink kiterjedtek a NOS3 enzim 
dimerizációját befolyásoló paraméterekre, mint például az Argináz-1 enzim jelenlétére, 
illetve az indukálható NOS (NOS2) enzim, mint egy lehetséges, „built in” kompenzációs 
mechanizmus aktiválódására. A vizsgált köldökzsinór és vörösvértest (VVT) minták érett 
és koraszülött iker és egyes terhességből született újszülöttektől származnak, különböző 
percentilis értékkel (25-95%). 
Főbb megállapításaink a következőkben foglalhatók össze: 
(1) Ikerterhesség alatt a köldökzsinór erekben a NOS3 útvonal a fejlődő magzat érettségi 
szintjétől - érett: > 37. hét, koraszülött: 33-35. hét - függően, valamint ér-specifikus módon 
szabályozott: 
(a) a terhesség 33-35. hetében a NOS3 expressziója és foszforilációja a Ser1177 
pozícióban az ikerterhességből származó köldökzsinór véna endoteliális sejtekben 
összevethető a korban megegyező egyes terhesség során mért adatokkal, függetlenül 
az újszülöttek súlyától 
(b) ezzel szemben a terhesség előrehaladtával (> 37. hét), a NOS3 expresszió 
jelentősen elmarad az egyes terhesség során mért szinttől, függetlenül az újszülöttek 
súlyától 
(c) a köldökzsinór artériákban, az érett, normál súlyú újszülöttektől eltekintve, nincs 
jelentős változás a NOS3 expressziójában / aktivációjában az egyes terhesség során 
mért adatokhoz képest 
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(2) Az érett, normál súlyú újszülöttek kivételével, a VVT-NOS3-NO útvonal jelentősen 
hozzájárulhat az értónus és ezzel a magzati véráramlás javításához, a magas NOS3 
expresszió és / vagy aktiváció következtében. 
(3) Valószínűsíthető, hogy a koraszülött ~ 95% percentilis újszülöttek kivételével, a 
biológiailag hozzáférhető NOS3-NO és VVT-NOS3-NO szint nem kielégítő, a magzat 
véráramlásának javítása érdekében alternatív NO-termelő útvonal, a NOS2 expresszió 
indukálódik. 
(4) Az iker újszülöttek vörösvértestjeiben az Arginase1 expressziójának emelkedett a 
szintje, mely részben a rendszerben nagymennyiségben termelődő szuperoxid anion 
jelenlétére vezethető vissza.  
(5) Ikerterhesség esetén a magzati vörösvértestekben megemelkedett a pro-oxidáns peroxi-
nitrit anion szint, mely szintén összefüggésbe hozható magas szuperoxid anion 
elérhetőséggel.  
(6) A peroxi-nitrit anion szinttel összefüggésben emelkedett membránkárosodás figyelhető 
meg, melynek meghatározására a hidroxi nonenal (HNE) akkumuláció mérését 
alkalmaztuk. Az érettségi szinttől függetlenül, elsősorban az artériák és a keringő VVT-k 
érintettek. A terhesség előrehaladtával az artériákban jelentősen nő a HNE szint.  
(7) Az újszülöttek érettségi szintjétől függetlenül a magzati vörösvértestekben 
megemelkedett a morfológiai variánsok száma iker terhesség során. Ezen fenotípusos 
eltérések hasznos indikátorként szolgálhatnak a funkcionális és / vagy fizikai-kémiai 





Figure S1. Representative epifluorescent images of the arterial endothelium in 
relation to NOS3 expression and its phosphorylation level. 
 
Representative epifluorescent images of immunolabelled arterial endothelium originated 
from Hws, Hwt, Lws, and Lwt samples. Panels (A, D, G, and J) show immunolabelling 
with mouse primary anti-NOS3 antibody followed by an Alexa Fluor® 488 secondary 
antibody. Panels (B, E, H, and K) show immunolabelling with a rabbit anti-pSer1177 
NOS3 primary antibody followed by an Alexa Fluor® 647 secondary antibody. Panels (C, 
F, I, and L) present the merged images. Slides were mounted and examined under an 
epifluorescence microscope (Nikon Eclipse 80i, 100x and 50x immersion objective; Nikon 
Zeiss Microscopy GmbH, Jena, Germany). 
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Figure S2. Representative epifluorescent images of the venous endothelium in 
relation to the NOS3 expression and its phosphorylation level. 
 
Representative epifluorescent images of immunolabelled venous endothelium originated 
from Hws, Hwt, Lws, and Lwt samples. Panels (A, D, G, and J) show immunolabelling 
with mouse primary anti-NOS3 antibody followed by an Alexa Fluor® 488 secondary 
antibody. Panels (B, E, H, and K) show immunolabelling with a rabbit anti-pSer1177 
NOS3 primary antibody followed by an Alexa Fluor® 647 secondary antibody. Panels (C, 
F, I, and L) present the merged images. Slides were mounted and examined under an 
epifluorescence microscope (Nikon Eclipse 80i, 100x and 50x immersion objective; Nikon 
Zeiss Microscopy GmbH, Jena, Germany). (Nikon Eclipse 80i, 100x and 50x immersion 
objective; Nikon Zeiss Microscopy GmbH, Jena, Germany). 
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Figure S3. Represents epifluorescent images of the arterial cord endothelium sections 
immunolabelled with the Arginase1, NOS2, and 4-HNE. 
 
Representative epifluorescent images of immunolabelled arterial endothelium originated 
from Hws, Hwt, Lws, and Lwt samples. The panels (A, D, G, and J) show immunolabelling 
with a mouse primary anti-Arginase1 antibody followed by an Alexa Fluor® 488 
secondary antibody. In a similar manner, panels (B, E, H, and K) present samples 
immunolabelling with a rabbit primary anti-NOS2 antibody followed by an Alexa Fluor® 
647 secondary antibody, and the panels (C, F, I and L) exhibit immunolabelling with a 
mouse primary anti-4-HNE antibody followed by an Alexa Fluor® 488 secondary 
antibody. The slides were mounted and examined under an epifluorescence microscope 





Figure S4. Visualization of the vein endothelium sections epifluorescent images 
immunolabelled with the Arginase1, NOS2, and 4-HNE. 
 
Representative epifluorescent images of immunolabelled venous endothelium originated 
from Hws, Hwt, Lws, and Lwt samples. The panels (A, D, G, and J) show immunolabelling 
with a mouse primary anti-Arginase1 antibody followed by an Alexa Fluor® 488 
secondary antibody. In a similar manner, panels (B, E, H, and K) present samples 
immunolabelling with a rabbit primary anti-NOS2 antibody followed by an Alexa Fluor® 
647 secondary antibody, and the panels (C, F, I and L) exhibit immunolabelling with a 
mouse primary anti-4-HNE antibody followed by an Alexa Fluor® 488 secondary 
antibody. The slides were mounted and examined under an epifluorescence microscope 




Figure S5. Representative epifluorescent images showing NOS3 and pNOS3 levels in 
the umbilical cord arterial endothelium 
 
Representative epifluorescent images on immunolabelled arterial endothelium originated 
from premature, non-discordant, high (Pr-Hwt), and low (Pr-Lwt) weight twins and age-
matched high weight singleton (Pr-Hws). Panels (A, D, and G) show immunolabelling 
with mouse primary anti-NOS3 antibody followed by Alexa Fluor® 488 secondary 
antibody staining. Panels (B, E, and H) show immunolabelling with a rabbit anti-pNOS3 
primary antibody followed by Alexa Fluor® 647 secondary antibody staining. Panels (C, 
F, and I) present the merged images. Slides were mounted and examined under an 
epifluorescence microscope (Nikon Eclipse 80i, 100x immersion objective; Nikon Zeiss 
Microscopy GmbH, Jena, Germany). 
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Figure S6. Representative epifluorescent images showing NOS3 and pNOS3 levels in 
the umbilical cord vein endothelium 
 
Representative epifluorescent images on immunolabelled venous endothelium originated 
from premature, non-discordant, high (Pr-Hwt), and low (Pr-Lwt) weight twins and age-
matched high weight singleton (Pr-Hws) samples. Panels (A, D, and G) show 
immunolabelling with mouse primary anti-NOS3 antibody followed by Alexa Fluor® 488 
secondary antibody staining. Panels (B, E, and H) show immunolabelling with a rabbit 
anti-pNOS3 primary antibody followed by Alexa Fluor® 647 secondary antibody staining. 
Panels (C, F, and I) present the merged images. Slides were mounted and examined under 
an epifluorescence microscope (Nikon Eclipse 80i, 100x immersion objective; Nikon Zeiss 
Microscopy GmbH, Jena, Germany). 
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Figure S7. Epifluorescent images represent arterial cord endothelium 
immunolabelled with Arginase1, NOS2, and 4-HNE 
 
Representative epifluorescent images on immunolabelled arterial endothelium originated 
from premature, non-discordant, high (Pr-Hwt), and low (Pr-Lwt) weight twins and age-
matched high weight singleton (Pr-Hws). Panels (A, D, and G) show immunolabelling 
with a mouse primary anti-Arginase1 antibody followed by Alexa Fluor® 488 secondary 
antibody staining. In a similar manner, panels (B, E, and H) present samples that were 
immunolabelled with a rabbit primary anti-NOS2 antibody followed by an Alexa Fluor® 
647 secondary antibody. Panels (C, F, and I) exhibit immunolabelling with a mouse 
primary anti-4-HNE antibody followed by an Alexa Fluor® 488 secondary antibody. The 
slides were mounted and examined under an epifluorescence microscope (Nikon Eclipse 
80i, 100x immersion objective; Nikon Zeiss Microscopy GmbH, Jena, Germany).  
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Figure S8. Epifluorescent images represent venous endothelium immunolabelled 
with Arginase1, NOS2, and 4-HNE 
 
Representative epifluorescent images on immunolabelled venous endothelium originated 
from premature, non-discordant, high (Pr-Hwt), and low (Pr-Lwt) weight twins and age-
matched high weight singleton (Pr-Hws) samples. Panels (A, D, and G) show 
immunolabelling with a mouse primary anti-Arginase1 antibody followed by an Alexa 
Fluor® 488 secondary antibody. In a similar manner, panels (B, E, and H) present samples 
that were immunolabelled with a rabbit primary anti-NOS2 antibody followed by an Alexa 
Fluor® 647 secondary antibody. Panels (C, F, and I) exhibit immunolabelling with a mouse 
primary anti-4-HNE antibody followed by an Alexa Fluor® 488 secondary antibody. The 
slides were mounted and examined under an epifluorescence microscope (Nikon Eclipse 
80i, 100x immersion objective; Nikon Zeiss Microscopy GmbH, Jena, Germany). 
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Figure S9. Representative epifluorescent images on umbilical cord arterial 
endothelium showing NOS3 expression and its phosphorylation level 
 
Representative epifluorescent images on immunolabelled arterial endothelium originated 
from premature, discordant, high and low-weight siblings (PrD-Hwt and PrD-Lwt). Panels 
(A, D) show immunolabelling with mouse primary anti-NOS3 antibody followed by an 
Alexa Fluor® 488 secondary antibody. Panels (B, E) show immunolabelling with a rabbit 
anti-pNOS3 primary antibody followed by Alexa Fluor® 647 secondary antibody staining. 
Panels (C, F) present the merged images. Slides were mounted and examined under an 
epifluorescence microscope (Nikon Eclipse 80i, 100x immersion objective; Nikon Zeiss 




Figure S10. Representative epifluorescent images on umbilical cord vein endothelium 
showing NOS3 expression and its phosphorylation level 
 
Representative epifluorescent images on immunolabelled venous endothelium originated 
from premature, discordant, high and low-weight twin pairs (PrD-Hwt and PrD-Lwt). 
Panels (A, D) show immunolabelling with mouse primary anti-NOS3 antibody followed 
by Alexa Fluor® 488 secondary antibody staining. Panels (B, E) show immunolabelling 
with a rabbit anti-pNOS3 primary antibody followed by an Alexa Fluor® 647 secondary 
antibody. Panels (C, F) present the merged images. Slides were mounted and examined 
under an epifluorescence microscope (Nikon Eclipse 80i, 100x immersion objective; 




Figure S11. Epifluorescent images represent arterial endothelium immunolabelled 
with Arginase1, NOS2, and 4-HNE 
 
Representative epifluorescent images on immunolabelled arterial endothelium originated 
from premature, discordant, high and low-weight twin pair samples (PrD-Hwt and PrD-
Lwt). Panels (A, D) show immunolabelling with a mouse primary anti-Arginase1 antibody 
followed by Alexa Fluor® 488 secondary antibody staining. In a similar manner, panels 
(B, E) present samples that were immunolabelled with a rabbit primary anti-NOS2 
antibody followed by Alexa Fluor® 647 secondary antibody. Panels (C, F) exhibit 
immunolabelling with a mouse primary anti-4-HNE antibody followed by an Alexa 
Fluor® 488 secondary antibody. Slides were mounted and examined under an 
epifluorescence microscope (Nikon Eclipse 80i, 100x immersion objective; Nikon Zeiss 
Microscopy GmbH, Jena, Germany).
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Figure S12. Epifluorescent images represent venous endothelium immunolabelled 
with Arginase1, NOS2, and 4-HNE 
 
Representative epifluorescent images on immunolabelled venous endothelium originated 
from premature, discordant, high and low-weight twin pairs (PrD-Hwt and PrD-Lwt). 
Panels (A, D) show immunolabelling with a mouse primary anti-Arginase1 antibody 
followed by Alexa Fluor® 488 secondary antibody staining. In a similar manner, panels 
(B, E) present samples that were immunolabelled with a rabbit primary anti-NOS2 
antibody followed by Alexa Fluor® 647 secondary antibody staining. Panels (C, F) exhibit 
immunolabelling with a mouse primary anti-4-HNE antibody followed by an Alexa 
Fluor® 488 secondary antibody. Slides were mounted and examined under an 
epifluorescence microscope (Nikon Eclipse 80i, 100x immersion objective; Nikon Zeiss 
Microscopy GmbH, Jena Germany) 
